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HSV-1 is a ubiquitous human pathogen with a biphasic lifecycle.  During latency, gene 
expression is globally repressed, most likely due to epigenetic mechanisms.  The HSV protein 
ICP0 is a promiscuous transactivator of gene expression, and is required for efficient viral 
reactivation from latency.  Evidence indicates that ICP0 interacts with a number of cellular 
pathways that mediate chromatin structure.  Using a cell culture model of latency, the effects of 
cell-type, ICP0 expression, and ICP0 functional domains on the chromatin structure of viral 
genomes was examined.  During viral entry into quiescence, ICP0 expression increased gene 
expression and histone hyperacetylation, while limiting the association of histones and 
heterochromatin with the viral genome.  In the absence of ICP0, expression from viral promoters 
was rapidly repressed, and heterochromatin formed on viral promoters in a cell-type specific 
manner.  Once quiescence was fully established, HSV genomes were found in a highly 
heterochromatic state.  Heterochromatin, measured by the presence of heterochromatin protein 
1γ and trimethylation of histone H3 lysine 9, was rapidly removed upon provision of ICP0 in 
trans.  The changes in epigenetic structure were global, and preceded reactivation of gene 
expression.  Overexpression of ICP0 resulted in the removal of histones from the quiescent 
genome, an effect not seen when ICP0 was expressed at physiological levels.  This indicated that 
ICP0 may be mediating its effects through multiple functions, potentially through the enzymatic 
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function of its RING finger (RF) E3 ubiquitin ligase domain when expressed at low levels, and 
through physical protein-protein interaction when overexpressed.  The effects on chromatin 
structure and gene activation of quiescent HSV were determined by superinfection with mutants 
of the RF domain and the C-terminus, which is important for the disruption of the 
CoREST/HDAC repressor complex.  The RF domain was necessary and sufficient for 
reactivation of gene expression, but full transcriptional activation and removal of 
heterochromatin and histones required both the RF and C-terminus of ICP0.  These results 
indicate that ICP0 relieves repression of gene expression through interactions with multiple 
cellular pathways.  Expression of ICP0 removes epigenetic repression at multiple levels of 
chromatin, including heterochromatin, histone deposition, and the acetylation of histones. 
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1.0  INTRODUCTION 
1.1 OVERVIEW 
Herpes simplex virus type 1 (HSV-1) is arguably the most successful human pathogen.  It infects 
the vast majority of the population, with which it has coevolved for thousands of years (206).  
HSV-1 is highly infectious, but does not greatly impair the normal function of its host, and may 
in fact be beneficial to its host’s survival (9). 
This success is due to the biphasic life cycle of HSV-1.  Following infection of epithelial 
cells, HSV undergoes a burst of lytic replication and infects the sensory neurons innervating the 
site of infection.  The viral DNA then establishes life-long latent infection in neuronal nuclei, 
where productive cycle gene expression is repressed, except in rare instances of reactivation.  
The global shutdown of gene expression allows the virus to evade the immune response and 
avoid viral clearance, and is most likely due to epigenetic mechanisms employed by the host 
cellular antiviral defense.  During reactivation and subsequent replication, the virus must 
counteract the suppression of gene expression. 
ICP0 is a viral protein required for efficient HSV establishment of infection, as well as 
reactivation from latency.  A large number of functions have been attributed to ICP0, including, 
but not limited to, activation of gene expression (49, 84) and interactions with cellular proteins 
involved in: transcription (44, 115), translation (114), cell cycle regulation (44, 257), the 
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interferon response (41, 169), and the double-stranded break repair mechanism (108, 188).  As a 
multifunctional activator of viral gene expression, ICP0 plays a key role in viral transcription, 
and may act as a molecular switch between the lytic and latent phases of the HSV-1 life cycle. 
There is mounting evidence that the functions of ICP0 are due to multiple interactions 
with cellular signaling pathways that affect chromatin structure.  The study presented here uses a 
cell culture model of quiescence that mimics aspects of in vivo latency, allowing for a detailed 
molecular study of the chromatin structure and kinetics of viral entry and exit from quiescence.  
The roles of cell type and functional regions of ICP0 upon the viral chromatin structure were 
explored, in addition to the effects that the abundance of ICP0 has on the epigenetic structure of 
the viral genome.  This study begins to elucidate the cellular metabolic pathways that are 
involved in control of HSV-1 through epigenetic mechanisms. 
1.2 PATHOLOGY, EPIDEMIOLOGY, GENOME STRUCTURE, AND LIFE CYCLE 
OF HSV-1 
1.2.1 Pathology and Epidemiology 
HSV-1 is a double-stranded DNA virus that establishes life-long infection in its host.  Almost 
100% of the human population is infected with HSV-1 (140) and approximately one third of 
people display clinical manifestations of infection (265).  HSV-1 is transmitted through direct 
skin to skin contact (264), and causes visible, painful, and embarrassing skin lesions, primarily in 
the region surrounding the mouth (207, 263).  HSV ocular diseases are among the leading 
infectious causes of blindness in many developed countries (141) and infection of the central 
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nervous system causes encephalitis, which can lead to brain damage and death (264).  HSV-1 
infection also increases the risk of HIV transmission (215). 
1.2.2 Structure and Life Cycle 
HSV-1 is an enveloped virus containing an icosahedral capsid that packages the viral genome.  
Between the capsid and envelope is an amorphous tegument layer that contains proteins which 
are important for the early stages of infection (10, 24, 238).  Glycoprotein spikes which mediate 
entry are embedded in the envelope (206).  The encapsidated HSV-1 genome is a linear double-
stranded DNA molecule composed of approximately 152,000 base pairs, with single-stranded 
nicks and gaps (204).  The genome is composed of two segments, the unique long (UL) and 
unique short (US), which are bracketed by inverted repeats (147).  The UL and US sequences are 
joined by internal repeat sequences.  The UL and US sequences can invert relative to one another, 
such that the genome can be found in four equimolar configurations (42, 94). 
Upon infection, HSV-1 undergoes an initial round of lytic replication in epithelial cells.  
HSV-1 encodes approximately 80 genes (204), which are grouped into three classes, and are 
expressed as a cascade during productive infection: immediate-early (IE), early (E), and late (L) 
(99, 100).  All viral genes are transcribed by the host RNA polymerase II machinery (207).  
Upon entry into a cell, the transcription of the IE genes is induced by the tegument-associated 
virion protein 16 (VP16) in complex with cellular host cell factor (HCF) and Oct-1 (10, 24), 
which recognize the IE gene promoters (71).  The five IE genes encode proteins that are 
primarily involved in the regulation of host cell metabolism and activation of viral gene 
transcription.  Infected Cell Protein 4 (ICP4) is required for the activated transcription of E and L 
 3 
genes (260). The E genes encode proteins involved in viral DNA replication, while the L genes 
produce mainly viral structural proteins (207). 
After infection of the mucosa or an epithelial abrasion, HSV-1 enters the endings of 
sensory nerves adjacent to the site of infection, and moves via retrograde axonal transport to cell 
bodies, where, after limited replication, it establishes a latent infection (250).  Primary lytic 
infection probably involves irregular histone association with viral genomes, although this is not 
conclusive (95, 96, 117, 136, 172).  In contrast, latent HSV-1 genomes are associated with 
heterochromatin and express little or no protein (43), although a class of mRNAs called latency-
associated transcripts (LATs) are expressed (230, 231). 
Because of the global nature of transcriptional repression during latency, HSV-1 probably 
relies on epigenetic control of expression to prevent gene expression.  DNA methylation is 
probably not the major means of control of HSV-1 gene expression because latent HSV-1 DNA 
is not extensively methylated (19, 128).  In contrast, a number of studies have implicated 
chromatin structure and specific histone tail modifications in the control of HSV-1 latency, 
reactivation, and replication (1, 20, 117, 128, 255, 259). 
1.3 CHROMATIN AND THE HISTONE CODE 
Eukaryotic DNA is associated in a chromatin structure with nucleosomes, which are octamers 
composed of two each of the histones H2A, H2B, H3 and H4 (123).  DNA wraps approximately 
1.65 times around each nucleosome (154), and may additionally be associated with the linker 
histone H1 between nucleosomes.  Thus, each nucleosomal structure of DNA is composed of 
145-200 base pairs of DNA.  
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Epigenetic regulation of gene expression entails the control of access to the DNA by 
regulatory elements such as transcription factors.  The occupational density of histones on DNA 
influences transcription because less occupied DNA is more open to transcription factors and the 
RNA polymerase II (pol II) is less impeded in its travel along the DNA.  Modifications of the N-
terminal histone tails, which protrude from the nucleosome, are also associated with control of 
transcription.  Modifications to the chromatin structure of DNA to control transcription have 
been elucidated in a “histone code” hypothesis (112).  Acetylation of lysines of histones H3 and 
H4 is associated with increased transcription.  This may be due to decreased positive charge of 
the histones, which bind less tightly to negatively charged DNA, thus allowing greater access to 
the DNA by transcription factors.  Some transcription factors contain bromodomains that bind 
acetyl-lysine.  Methylation of histone tail residues is more complicated.  For example, 
methylation of histone H3 lysine 4 is associated with transcription activation, while methylation 
of histone H3 lysine 9 is associated with transcriptional repression.  Proteins with 
chromodomains can bind methylated lysines and cause repression or activation of transcription 
(202).  Other modifications of histones include phosphorylation, ubiquitylation and 
SUMOylation (276). 
Histone tail modifications may also influence their ability to bind to the major or minor 
groove of DNA on their own or neighboring nucleosomes, which influences accessibility to 
transcription factors (251).  These modifications also recruit proteins that are involved in forming 
a higher order chromatin structure, known as heterochromatin, which is extremely repressive to 
transcription.  Proteins such as heterochromatin protein 1 (HP1), which binds to methylated 
histone H3 lysine 9, help nucleosomes form this more compact and dense heterochromatin (177, 
251).  
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Cells use a regulatory control network of histone chaperones and modifying enzymes to 
control the epigenetic state of their genes.  Deposition of histones on DNA is controlled by 
histone chaperones such as ASF and CAF1 (187).  Chromatin can be modified by remodeling 
enzymes such as members of the SWI/SNF family (276).  The modifications of histone tails are 
controlled by numerous enzymes, including histone acetyltransferases (HATs), histone 
deacetylases (HDACs), histone methyltransferases (HMTs), and histone lysine demethylases 
such as LSD1 (221). 
There is crosstalk between histone modifications at one residue of the histone tail and 
those at another (40), as well as between histone tails and DNA (227), such that modification of 
a specific residue of a histone influences the modification state of other histone residues.  This 
crosstalk extends to the DNA.  Repressive histone modifications are linked to the methylation of 
DNA, which also represses transcription (227). 
1.4 ESTABLISHMENT OF QUIESCENCE 
1.4.1 Localization of the quiescent genome 
Latent infection is established in the nuclei of infected neurons (76).  A more detailed 
determination of viral gemome nuclear localization in neuronal cells has been difficult due to the 
lack of suitable antibodies for immunofluorescence studies in mouse and rat neuronal cells (101).  
Using cell culture systems, it has been determined that HSV genomes localize to the periphery of 
newly formed Nuclear Domain 10 (ND10) structures during the early stages of lytic infection 
(59, 64, 105, 161).  This is consistent with the observation that other DNA viruses are deposited 
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near ND10 sites (105, 159).  Quiescent HSV genomes are also associated with ND10 in human 
fibroblasts (60). 
1.4.2 ND10 bodies 
ND10 (or PML) bodies are small structures found in the nucleus that are organized by the protein 
PML.  ND10 bodies are thought to be part of the innate cellular defense against viral infection 
(50), and in fact, overexpression of the ND10 components PML and Sp100 is able to cause 
repression of HSV-1 in the absence of ICP0.  Upon expression of ICP0, PML and Sp100 are 
degraded (25, 57).  Numerous other proteins localize to ND10 bodies, including HP1, which is 
associated with heterochromatin (56), as well as hDaxx (56, 107), and ATRX (107), which are 
members of transcriptionally repressive chromatin modifying complexes.  These observations 
support the hypothesis that ND10 bodies repress viral transcription through epigenetic 
mechanisms. 
1.4.3 Circularization of the Genome 
Upon entry into the nucleus, HSV begins its gene expression cascade.  If it is able to replicate, 
genomes can be found in many complex configurations, including full length linear genomes, 
complicated branched structures, and circular forms (70, 109), but all available evidence points 
to a circular episomal latent form of HSV DNA. 
In latently infected mice, HSV DNA can be found in an “endless” configuration, 
determined by an increase in the joint fragments and a decrease in the terminal fragments in 
Southern blots of mouse neuronal tissue (46, 203).  All four isomeric arrangements of the 
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genome were found and these results extended to analysis of human trigeminal ganglia (46).  
This increase in joint fragments has been found in quiescently infected PC12 cells (239) and 
Vero cells (108).  A decrease of genomic termini could also mean that the quiescent genome is 
integrated into cellular DNA, but there is no evidence to support this possibility (164).  Vero 
cells also showed an increase of circular DNA in relation to linear DNA in Gardella gel analysis 
(108).  Circular HSV DNA is also extremely stable in cell culture, detectable 3-4 weeks post 
infection (108, 239).  It is likely that latent viral DNA is found in a circular episome, both in 
vitro and in vivo. 
The appearance of circular DNA occurs in the absence of de novo viral protein synthesis 
(108, 193).  This suggests that cellular factors, such as DNA repair proteins, are responsible for 
the circularization of the quiescent viral genome.  In fact, the ATM DNA damage response is 
activated upon infection of some cell types by HSV (142, 226); cellular recombination and repair 
proteins are recruited to sites of HSV DNA replication (275); and Mre11, a downstream effector 
of ATM, is degraded upon HSV infection of some cell types (77). 
1.4.4 Methylation of viral DNA is not a means to repress transcription 
Gene expression of circular latent viral genomes is generally repressed, except for LAT mRNA.  
The global nature of HSV gene repression suggests an epigenetic mechanism of transcriptional 
silencing.  One possible mechanism is the methylation of DNA.  HSV DNA has a very high CG 
content (206), which if methylated, could be silenced by the physical barrier to transcription, as 
well as the recruitment of methyl-CpG-binding domain proteins.  This is not the case, however, 
as HSV DNA is not extensively methylated in vivo (45, 128).  Thus, in the most sophisticated 
study of latent HSV DNA methylation to date, regions of the HSV genome likely to be 
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methylated were identified by bioinformatic analysis, and these regions were tested for 
methylation using bisulfite sequencing of latently infected mouse dorsal root ganglia (128).  This 
study also found that chromatin structure correlated with gene activity.  Histone modifications 
indicative of active gene expression were found within the active LAT region and modifications 
correlating with repression of transcription were found at the inactive HSV-1 DNA polymerase 
gene. 
1.4.5 Deposition of histones on viral DNA and the formation of nucleosomes 
Mounting evidence indicates that chromatin structure is a major determinant of HSV gene 
expression, both during lytic and latent infection.  Chromatin structure exists on a number of 
levels, including deposition of histones on DNA, covalent modification of the histone tails, 
recruitment of non-histone proteins to the chromatin fiber, and folding into higher order 
chromatin structures (Figure 1). 
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Figure 1.  Levels of epigenetic repression of HSV-1 transcription. 
As the viral genome enters quiescence, it acquires increasingly higher-order chromatin structure.  The order of 
heterochromatin acquisition is not fully defined, but higher amounts of heterochromatin are associated with greater 
repression.  
 
 
 
Initial studies of the chromatin structure of HSV utilized micrococcal nuclease digestion 
of radiolabelled DNA of cultured cells.  Lytic infection of rat liver cells – labeled with 
[3H]thymidine either pre- or post-infection – revealed that the chromatin structure of replicating 
virus differed from that of cellular chromatin, producing a “smeared” pattern upon limited 
digestion while the pattern of cellular DNA did not change (171).  This indicated that replicating 
viral DNA either did not associate with nucleosomes, or that there was random association of 
nucleosomes with viral DNA.  These results were similar in nature to a more in-depth study of 
the betaherpesvirus Epstein Barr Virus (EBV).  Micrococcal nuclease digestion and Southern 
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hybridization of EBV-infected non-producing (i.e. quiescent) Raji cells showed that the 
quiescent genomes were in a nucleosomal structure similar to that of cellular DNA.  However, 
EBV-producing (i.e. lytic) P3HR-1 cells, containing replicating virus, were only minimally 
associated with nucleosomes (222), as demonstrated by a faint banding pattern superimposed 
upon a smear of viral DNA. 
By pulse labeling DNA upon infection of Vero cells, it was found that parental HSV 
DNA is at least partially nucleosomal, while progeny DNA is found in a similar bands-on-a-
smear pattern as replicating EBV DNA (136).  A high molecular weight band of DNA was 
found, even after micrococcal nuclease digestion.  This is presumably encapsidated DNA 
protected from enzymatic cleavage.  Southern blotting with a full HSV DNA probe in this 
system also found a pattern of bands on a smear (136).  In another study, complete micrococcal 
nuclease digestion of lytically infected Sy5y cells, a human neuroblastoma line, showed a band 
of mononucleosomal length, indicating that there is at least minimal association of nucleosomes 
with HSV DNA during lytic infection (117). 
The cell culture micrococcal nuclease data of lytic infection was confirmed in an animal 
model system.  Comparing lytic infection of the C1300 neuroblastoma cell line and the 
brainstems of acutely infected female BALB/c mice, it was found that most viral DNA from 
productive infection digested in a bands-on-a-smear pattern, indicating that both in vitro and in 
vivo lytic infection results in a population of viral genomes largely devoid of nucleosomal 
structure (172).  These results cannot, however, distinguish between a single population of 
genomes with irregular nucleosome association and two distinct populations of genomes – one 
nucleosome-free, the other consisting of genomes regularly associated with nucleosomes.  
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Additionally, this study also concluded that encapsidated viral DNA was protected from 
micrococcal nuclease digestion (172). 
A study of latently infected female BALB/c mice corroborated the previous cell culture 
EBV data.  HSV genomes during lytic infection are partially or irregularly nucleosomal, while 
latent HSV DNA is found in a nucleosomal structure similar to that of cellular chromatin, as 
determined by the typical banding pattern of nucleosomal DNA upon incomplete micrococcal 
nuclease digestion.  Both full-length HSV genomic probes and subgenomic probes spanning 
different regions of the genome were tested, indicating that nucleosomal association is regular 
across the genome (43).  Additionally, micrococcal nuclease digested DNA from latently 
infected mice did not contain a high molecular weight band, indicating that no encapsidated 
genomes were present (43).  A more recent study of quiescently infected human fibroblasts came 
to different conclusions about the nucleosomal association of the tk gene.  Cells were treated 
with interferon-α and AraC to induce quiescence of a and a mutant virus deleted for the VP16 
gene.  It was found that quiescent DNA of the tk gene was not associated with nucleosomes in a 
regular pattern (110).  Upon micrococcal nuclease digestion, a smear was seen when DNA was 
probed for the viral tk gene.  This may have been due to low-level expression of viral genes in 
the fibroblast quiescence model.  Additionally, viral DNA was more protected from digestion 
than the cellular DNA.  This may indicate that quiescent infection of fibroblasts results in denser, 
higher order chromatin structure that is more resistant to micrococcal nuclease digestion than 
simple nucleosomal DNA.   
These micrococcal nuclease digestion data indicate that the cell culture model is a good 
model for the epigenetic structure of latent HSV in vivo.  The data indicate that the quiescent and 
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latent HSV genome is circular and found in a chromatin arrangement that is at least as protected 
from micrococcal nuclease digestion as bulk cellular DNA, and possibly more so.  
The encapsidated viral genome is not associated with histones (183).  As a result, when 
the capsid reaches the nucleus of the infected cell, it injects naked, linear DNA into the nucleus.  
This DNA may be recognized as foreign, which will initiate the innate immune response of the 
cell, or it may be recognized as damaged DNA.  Recognition of this naked DNA prompts the cell 
to deposit histones on the incoming genome.  Histone deposition is mediated by histone 
chaperones, such as Chz1 (which binds the H2A/H2B dimer) and CAF1 (which binds H3/H4) 
(187).  In order to initiate the lytic cycle, HSV expresses proteins that either prevent histone 
deposition or remove deposited histones from the viral genome.  
In order to gain a more detailed understanding of the chromatin state of latent HSV, 
chromatin immunoprecipitation (ChIP) has been utilized.  ChIP consists of four basic steps: (i) in 
situ crosslinking of protein to DNA, generally using formaldehyde, (ii) isolation and shearing of 
DNA to slightly larger than nucleosomal size, (iii) selective immunoprecipitation of proteins of 
interest, to the resolution of specific histone tail modifications, followed by isolation of the 
bound DNA and (iv) amplification of DNA sequences of interest by qPCR to determine the 
percent bound by the protein of interest (129).  The following studies utilized ChIP to better 
understand the regulation of HSV gene expression. 
Lytic HSV infection does not affect the total amount of cellular histone H3 in Sy5y cells 
(117), but it encodes a number of proteins that may prevent histone deposition on the genome.  
VP22 is one of the most abundant tegument proteins, and is available to the virus immediately 
upon infection.  In COS-1 cells VP22 binds to and colocalizes with the histone chaperones 
template-activating factor I α and β (TAF-Iα and –Iβ) (255), which have been reported to 
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facilitate nucleosome formation on naked DNA (184).  VP22 was also found to prevent the 
ability of TAF-I to reconstitute nucleosomes on plasmid DNA in vitro (255).  VP22 may act in a 
nonspecific manner to prevent histone deposition. 
Another tegument protein, VP16, activates the transcription of immediate early genes and 
recruits the chromatin remodeling proteins and transcriptional activators BRG1 and BRM to viral 
promoters in HeLa cells.  VP16 also causes the underrepresentation of histone H3 in an 
activation domain-dependent manner (95); this effect is targeted to the promoters of IE genes.  
Transcription of IE genes allows the expression of ICP0, the promiscuous viral transactivating 
protein.  ICP0 is a multifunctional protein that causes the proteosomal degradation of a number 
of proteins through its E3 ubiquitin ligase domain (48, 256).  Expression of ICP0 increases the 
expression of all classes of viral genes, at least partially by manipulating the host chromatin 
modifying machinery.  Recently it has been reported that ICP0 removes histone H3 from the 
viral genome during lytic infection of HeLa cells (29). 
Because of the numerous strategies HSV employs to prevent histone deposition on its 
genome, it seems likely that latent genomes are generally associated with high levels of histones, 
which could help to physically block the transcriptional machinery.  In male Cd-1 mice, histone 
H3 association with the ICP4 and tk promoters does not increase during the first 5 days post-
infection, while the initial infection replicates.  After 5 days post infection, however, histone H3 
on the ICP4 promoter increased by over 10-fold, and histone H3 association with viral promoters 
increased through day 30 post infection (259). 
ChIP and micrococcal nuclease digestion experiments in vitro and in vivo show that 
latent HSV is found in a nucleosomal structure during latency.  This implicates histone and 
nucleosomal association with the viral genome as methods of cellular control of viral gene 
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transcription.  Transcription can still occur, despite histone association with the virus, but this is 
the first cellular level of defense.  Modifications of histone tails are a major determinant of 
whether the virus enters the lytic cycle or latency. 
1.4.6 Histone tail modifications on the quiescent viral genome – entry into 
heterochromatin 
During latency, the lytic cascade is abrogated and LAT expression predominates.  In an in vitro 
neuronal culture utilizing viruses with reporter genes under control of lytic cycle or LAT 
promoters, it was seen that initial expression from lytic cycle promoters was gradually shut down 
over time, while expression from the LAT promoter was found at early times post infection and 
is stably maintained in culture (4). 
It has been found that chromatin structure is necessary to block gene expression of 
quiescent DNA.  In addition to prevention of histone deposition, HSV encodes a number of 
functions to block heterochromatin-associated histone modifications from occurring on its 
genome.  Lytic HSV infection of Sy5y cells modestly increases the total cellular amount of the 
transcriptionally active histone modifications H3 acetyl lysine 9 (H3K9Ac) and H3 acetyl lysine 
14 (H3K14Ac) by 1.5- to 2-fold, while decreasing the amount of dimethylated H3 lysine 9 
(H3K9me2), a mark of inactive transcription, by approximately 2-fold (117).  The same study 
found that lytic HSV increased its association with histones bearing the active chromatin marks 
H3K9Ac, H3K14Ac, and H3K4me3, while maintaining low levels of association of the 
repressive mark H3K9me2 (117).  It was later found that inhibition of methylation by the histone 
H3K4 methyltransferase reduces the amount of H3K4me3 on the HSV genome and also results 
in decrease replication and transcription of HSV (103).  These observation in lytic cell culture 
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models indicate that the latent HSV genome is likely to be hypoacetylated on inactive genes and 
hyperacetylated on active genes.  
VP16 plays a role in recruiting the HATs p300 and CBP to immediate early promoters 
during infection of HeLa cells, which results in an increase in hyperacetylated H3 (AcH3) 
relative to total H3 at these promoters (95).  The viral Us3 kinase has also been reported to 
increase gene transcription in a manner similar to the HDAC inhibitor sodium butyrate in SK-N-
Sh cells by causing the phosphorylation and redistribution of HDAC1 (194). 
Most of the research on HSV interference with chromatin modification machinery has 
focused on ICP0.  Viruses lacking ICP0 are poorly replicating in most cell types, and show 
significantly decreased expression of viral genes (210, 237).  ICP0 is a key activator of the lytic 
cycle.  In HeLa cells, the ICP8 gene is associated with hyperacetylated histones in the presence 
of ICP0 (29).  This effect may be mediated by the reported interaction of ICP0 with class II 
HDACs (153), or its disruption of the neuronal REST/CoREST/HDAC1/HDAC2 repressor 
complex in HeLa, SK-N-SH, HEL, and HEK293 cells (78, 81).  The REST/NRSF DNA binding 
site has been reported to be in proximity of the ICP22 and ICP4 IE genes.  Transient transfection 
assays in HEK293 cells indicate that REST/NRSF reduces transcription from the ICP4 and 
ICP22 promoters, and binds in the proximity of and reduces histone H4 acetylation of the ICP4 
promoter (190).  The REST/NRSF binding site is not necessary, however, for entry into 
quiescence.  A mutant lacking the REST/NRSF binding site, which does not express any IE 
genes, can stably enter quiescence in Vero and HEL cells (211).  
Multiple studies have also determined that HDAC inhibitors can at least partially 
substitute for ICP0, relieving transcriptional repression in the absence of the protein (4, 39, 97, 
195).  In certain cell types, however, as quiescence progresses HDAC inhibitors decrease in their 
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ability to functionally substitute for ICP0, indicating the ICP0 has functions in addition to HDAC 
inhibition (246).  
In quiescently infected MRC-5 cells, the ICP0 promoter was enriched in the repressive 
chromatin marks H3K9me and H3K9me3 prior to reactivation induced by superinfection.  
Concurrently, the ICP0, ICP27, gC, and LAT promoters were hypoacetylated on histone H3 
prior to superinfection (32).  In contrast, in latently infected female Swiss Webster mice, the 
LAT promoter is enriched in hyperacetylated H3 (AcH3), which may reflect differences between 
LAT expression in vitro and in vivo.  The findings that lytic gene promoters are associated with 
hypoacetylated histone H3 concurred with the in vitro data (128).  Another in vivo study using 
male CD-1 mice has also determined by ChIP that LAT expression affects the histone 
modifications on viral promoters.  LAT expression was associated with an increase of the 
heterochromatic modification dimethyl H3 lysine 9 (H3K9me3) and a reduction of the 
transcriptionally active H3K9me2 on lytic gene promoters (259).   
Studies of the histone changes associated with lytic virus suggest that histone 
modifications play a major role in viral expression.  Hyperacetylation of histones and 
methylation of histone H3K4 are modifications associated with active chromatin, and are 
associated with gene expression from the lytic HSV genome.  The ability of HDAC inhibitors to 
partially substitute for ICP0 highlights the importance of acetylated histones to viral 
transcription.  These studies also suggest that quiescent HSV, in addition to being associated 
with hypoacetylated histones, is further repressed in a manner that is insensitive to HDAC 
inhibitors. 
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1.4.7 Higher order chromatin structure 
The decreasing ability of HDAC inhibitors such as trichostatin A (TSA) to reactivate quiescent 
HSV in mouse TG explant cultures as the infection proceeds (246) implies that there are 
additional barriers to gene expression in the chromatin state of the repressed genome.  
Additionally, quiescent genomes lacking ICP0 in HEL cells are not reactivated upon 
superinfection with virus also lacking ICP0, despite the replication of the superinfecting genome 
(168).  ICP0 is required for reactivation of these quiescent genomes. 
Few studies have addressed the higher order chromatin structure of quiescent virus, but 
some aspects of its structure can be inferred by studies of lytic virus.  An early study of nuclear 
sedimentation rates of chromosomal DNA in HeLa cells indicated that infection by HSV induced 
disruption of higher-order chromatin structure (3).  HSV has also been reported to mobilize 
linker histone H1, a key component of the 30nm fiber of higher order DNA folding (90), in Vero 
cells (33). 
ICP0 expression induces the degradation of the centromeric histone H3 variants CENP-A 
in HeLa, HFL, and Hep2 cells (152), CENP-B in HeLa and NIH3T3 cells (151), and CENP-C in 
Hep2 cells (55).  These proteins help to form the kinetochore and begin assembly of the 
centromere (219).  This may be a strategy by the virus to stall the cell cycle of actively dividing 
cells (97, 150), or it may be a byproduct of the destruction of ND10, as a significant number of 
proteins can be found in both ND10 and centromeres (56).  It may also interfere with the 
formation of heterochromatin on the viral genome, a prospect that requires further study.  The 
ICP0 promoter of quiescent genomes lacking VP16, ICP0 and ICP4 expression in MRC-5 cells 
is associated with HP1α (32), which is a constituent of heterochromatin (149). 
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Both in vitro and in vivo studies have found that the quiescent genome is found in a 
circular episome.  The quiescent genome is also associated with nucleosomes containing histones 
with modifications corresponding to transcriptional repression.  Specifically, histones are 
hypoacetylated, there is a decrease of the active mark H3K4me, and an increase in the repressive 
modifications H3K9me, H3K9me2, and H3K9me3.  This modification is known to recruit the 
HP1 chromodomain, and the HP1γ isoform is recruited to quiescent HSV genomes in at least 
some cell types.  The cumulative results of these studies demonstrate that as the genome enters 
quiescence, it acquires increasing chromatin structure, until it is tightly packaged in a higher-
order chromatin structure. 
1.5 MAINTENANCE OF QUIESCENCE 
1.5.1 Differences between maintenance of cell culture quiescence and latency 
There are a number of differences between in vitro quiescence and in vivo latency.  Quiescent 
genomes in human fibroblast cultures are associated with ND10 (60), and while there is a dearth 
of data corresponding to specific cellular location of the latent viral genome, some evidence has 
shown that neurons either lack ND10, or have limited or different ND10 structures in 
comparison to fibroblasts in cell culture (101, 106, 175).  ND10 structures have a role in the 
repression of HSV replication, but the mechanism by which ND10 exert their influence is 
unclear. 
Mutants of HSV used to establish quiescent cell culture infections almost invariably have 
ICP0 mutations, truncations, or complete knockouts.  These methods to suppress gene expression 
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necessarily also interfere with the structure of the LAT gene.  The function of the LAT gene and 
its transcripts has been the subject of some controversy.  In the mouse it has been reported that 
LAT expression promotes the assembly of heterochromatin on lytic genes (128, 259),  while in 
the rabbit it has been shown to promote euchromatin assembly on, and increase transcription of, 
lytic genes during latency (73).  These two sets of results may be due to the different models 
used.  LAT also reportedly prevents splicing of the primary ICP0 transcript (156), protects 
neurons of the TG from apoptosis (18), and encodes a microRNA responsible for reduction in 
ICP0 protein expression, in both Vero cells and mice (252).  To complicate matters, it appears 
that LAT, and most viral proteins, are dispensable for establishing quiescence in cell culture 
(209, 211).  Clearly, more study of the function of LAT is required, and quiescent cell culture 
models containing intact LAT could help by providing a less complex system. 
Additionally, cell culture models examining maintenance of quiescent HSV infection are 
only poorly able to mimic immune conditions found in vivo.  Addition of interferon to cultures 
has been used to establish quiescent infection, but it is not absolutely necessary.  Some in vivo 
studies of latent HSV have shown an activated immune response in latently infected mice, which 
helps to prevent HSV reactivation (67, 118, 223, 247).  It appears that through immune 
activation, the host contributes to the perpetuation of the latent state.  This may be beneficial to 
both host and virus, as it allows viral survival, while also minimizing immune-mediated damage 
to the host. 
1.5.2 The structure of quiescent HSV and the maintenance of latency 
Despite their limitations, cell culture models of latency can give us insights into both the viral 
and cellular mechanisms involved in maintaining quiescence.  One of the major characteristics of 
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HSV is its ability to maintain lifelong infection of its host.  This is accomplished through latency, 
during which the virus is able to effectively maintain its genome in non-dividing sensory neurons 
while “hiding” from the immune system.  The virus is able to accomplish this in part through the 
structure of the quiescent genome.  In cell culture, circular episomes are more stable than their 
linear counterparts (108, 239), and “endless” circular configurations are found in vivo as well 
(46, 203).   
The shutdown of activated expression of lytic transcripts during latency may be part of a 
viral strategy to evade the immune system and prevent long term damage to its host.  The 
chromatin structure of the virus may be able to block activated gene expression, which limits 
viral toxicity to its host cell and activation of the immune system.  Quiescent infection of Vero 
cells with a viral mutant lacking all IE gene expression did not affect cell survival, and infection 
of HFL cells did not disrupt ND10 (211).  
In a rat neuronal culture system utilizing various replication-defective reporter mutants, 
lytic promoters were found to be active upon infection and shut down over time, while LAT 
expression was evident in neurons at early times post infection and was stably maintained for 
several weeks (4).  Together with the data finding that LAT expression, at least in some animal 
models, is able to down-regulate lytic gene expression through both miRNA and chromatin 
structure (252, 259), it appears that lytic gene shutdown is part of a viral strategy to maintain 
latency.  
LAT expression plays an important, if poorly understood role in HSV latency in vivo.  In 
order to express LAT while globally repressing the genome, the virus must have a mechanism to 
maintain LAT in a more open chromatin structure.  An early cell culture study of the 
Pseudorabies Virus LAT promoter inserted into differing regions of the HSV genome suggested 
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a positional effect on expression (102).  When inserted into the LAT promoter region of HSV, 
expression was seen in cells of neuronal origin, but when inserted in the place of gC, expression 
was greatly repressed. 
A study of latently infected female Swiss Webster mice revealed that the LAT enhancer 
is associated with hyperacetylated histones, but that this pattern does not extend into the ICP0 
promoter region; indeed, no lytic genes tested contained regions of hyperacetylated histones 
(127).  This effect was maintained in the presence or absence of LAT transcription, indicating 
that HSV employs a mechanism independent of transcription to maintain an active chromatin 
state on LAT during latency.  This study suggested that a boundary element was present to 
maintain two distinct chromatin domains on the latent HSV genomes.  Further in vitro and in 
vivo studies, while disagreeing slightly, found that there is a CTCF-dependent chromatin 
insulator element between LAT and the ICP0 promoter, allowing LAT to maintain an active 
chromatin state, while ICP0 and other lytic genes are found in heterochromatin (2, 26). 
In order to maintain latency, the HSV genome adopts a stable, circular, episomal 
structure that is bound by nucleosomes.  Expression from the LAT region appears to promote the 
assembly of heterochromatin on lytic regions of the genome, which are globally repressed by 
their structure.  The LAT promoter is bounded by an insulator that allows it to remain associated 
with hyperacetylated histones and continue expression, while the bulk of the latent genome 
remains repressed, effectively allowing it to evade the immune system and maintain infection 
throughout the life of the host. 
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1.6 EXIT FROM QUIESCENCE/REACTIVATION 
1.6.1 Differences between cell types and states of latency 
Multiple levels of control regulate gene expression in eukaryotic cells.  Availability of 
transcription factors and specific DNA sequences regulate expression from naked DNA.  
Nucleosome and histone binding and placement require additional cofactors to aid transcription 
and remove histones from the path of the RNA polymerase II holoenzyme (138).  Specific 
histone tail modification can further regulate transcription, either positively or negatively, and 
greater DNA folding due to linker histone association and non-histone proteins associated with 
chromatin can limit access of transcriptional machinery to the genome and further repress gene 
expression. 
Despite its repressive chromatin structure, some expression of lytic genes from latent 
HSV is observed, both in vitro and in vivo (66, 126).  Additionally, chronic immune activation of 
latently infected hosts implies that at least some protein expression occurs during latency in vivo.  
The mechanism that changes the viral expression pattern from the latent program to the lytic 
cycle is unclear.  Cellular stress (36, 38, 148, 197, 274) and decrease in immune function can 
both reactivate HSV (67).  The exact order of gene expression upon reactivation is unclear, but 
latently infected explanted mouse TG were shown to express genes out of the order of the lytic 
cascade (242), while there is reportedly a decrease in LAT prior to, or concurrent with, lytic gene 
expression (231, 274). 
One hypothesis explaining reactivation is that during latent infection, some genomes are 
found in a less repressed state, allowing for stochastic gene expression and less restricted 
reactivation.  This would help to explain chronic immune activation during latent infection, as 
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there would be low level antigen present throughout infection.  Using a GFP reporter gene under 
control of the HCMV promoter, it has been found that cell types vary greatly in their ability to 
repress expression from quiescent genomes expressing no IE genes.  The osteosarcoma cell line 
U2OS expressed GFP in 99% of cells, while HEL cells expressed GFP in less than 1% of cells.  
Additionally, in primary cultures of murine TG, neurons expressed GFP during quiescent 
infection, while support cells rarely demonstrated GFP expression (246).  
Even cells of the same type within the same culture differentially repress quiescent virus.  
Low MOI infection of human fibroblasts with a mutant HSV strain lacking ICP0 expression 
established quiescent infection.  Nonproductive infection varied greatly between cells, with some 
expressing no detectable viral protein, others expressing some IE proteins, still others expressing 
all IE proteins, and some stalling at an early protein expression phase, prior to DNA replication 
(53).  Similarly, reactivation of HSV in quiescently infected PC12 cells in response to stress only 
moderately increases expression of the viral genes ICP0, ICP4, or LAT, and does not increase 
average expression of VP16 and ICP27 (38).  This lack of global viral transactivator expression 
indicated that virus from only a small proportion of cells initiated reactivation. 
These in vitro studies of differing states of latency correlate with in vivo studies.  In male 
Swiss Webster mice, it was found that few latently infected neurons were able to reactivate in 
response to hyperthermic stress (214).  Another study of latently infected ICR mice demonstrated 
differing populations of neurons, with reactivation by explant cultivation occurring specifically 
in those neurons expressing cdk2 (216).  
These results, which show levels of expression differing between cell type and even 
between neighboring cells of the same type in culture, suggest that repression of viral gene 
expression varies.  This variation of repression is likely to be the result of differences in 
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epigenetic structure.  Cellular chromatin varies from cell to cell in its protein association, nuclear 
position, and three dimensional structure, even at the same locus (74).  It seems likely that viral 
chromatin behaves similarly. 
In order to undergo reactivation of gene expression, quiescent viral genomes likely must 
change chromatin structure.  HDAC inhibitors such as TSA and sodium butyrate can induce 
reactivation of replication competent quiescent virus in PC12 cells (39).  TSA can also induce 
reactivation of gene expression in quiescently infected neurons in explant cultures from mice 
(246) and rats (4).  TSA induced reactivation was limited in both cases to reporter gene 
expression from neurons.  It appears that HSV in quiescently infected support cells requires more 
than histone acetylation to reactivate gene expression.  Provision of ICP0 by superinfecting virus 
was able to reactivate gene expression in mouse neuronal cultures (246).  This indicates that the 
functions of ICP0 include more than HDAC inhibition, and that quiescent virus in some cell 
types is in a higher order chromatin structure refractory to activation by histone acetylation 
alone. 
The presence of ICP0 is critical for effective viral reactivation from latency (21-23, 85, 
86, 113).  Using a reporter gene controlled by the ICP0 promoter in quiescently infected rat 
neuronal culture, it was determined that the ICP0 promoter is able to reactivate expression upon 
addition of TSA.  It has been shown in HEL cell culture that levels of ICP0 1000-fold less than 
typical lytic infection levels are able to efficiently reactivate reporter gene expression from 
quiescent genomes (96).  These observations suggest that perturbation of the chromatin structure 
of ICP0 in a small number of viral genomes can initiate ICP0 expression, which can further alter 
chromatin of the quiescent viral genome, allowing viral reactivation without significant changes 
in gene expression or average chromatin structure of the quiescent viral genomes. 
 25 
Cell type differences in chromatin structure of latent HSV are likely to allow a minority 
of latent virus to reactivate.  Upon reactivation, these viruses may spread and provide the 
impetus to begin reactivation in cells previously refractory to reactivation.  In order to express 
viral lytic genes and eventually replicate the genome, latent HSV must undergo structural 
changes. 
1.6.2 Changes in epigenetic structure upon reactivation 
Few studies have investigated the changes to viral chromatin upon reactivation of quiescent or 
latent virus.  One study employed a fibroblast model of quiescence utilizing replication-deficient 
HSV mutants, followed by derepression due to the provision of ICP0 (32).  Upon ICP0-mediated 
derepression, histone levels remained essentially the same on quiescent genomes, as determined 
by ChIP.  After superinfection with an adenovirus providing ICP0, an increase in AcH3 was 
found on the ICP0, ICP4, ICP27, VP16, gC and LAT promoters, and a decrease in the repressive 
modification H3K9me3 was found on the ICP0, ICP27, VP16, and gC promoters.  These results 
demonstrate that derepression of quiescent genomes by ICP0 induces a global change in 
chromatin structure, specifically the acetylation of histones associated with quiescent viral 
genomes. 
Corresponding to this in vitro study, in a BALB/c mouse model, it was found that sodium 
butyrate treatment of latently infected mice induced reactivation.  Using ChIP, it was determined 
that acetylation of histones at the LAT promoter decreased soon after sodium butyrate treatment, 
with a corresponding decrease in LAT expression, while the ICP0 and ICP4 promoters became 
hyperacetylated (176).  These findings agree with those of a previous ChIP study of latently 
infected mouse dorsal root ganglia explants, in which the LAT promoter became hypoacetylated 
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post explant, corresponding to decreased LAT expression, while the ICP0 promoter became 
hyperacetylated (1). 
The discrepancy between the in vitro and in vivo data on the structural changes to LAT 
chromatin induced by reactivation can be explained in several ways.  It is possible that there is an 
in vivo mechanism by which LAT is treated differently than the bulk of the viral genome in cell 
culture.  This may be a consequence of immune interaction with latently infected cells.  
Alternatively, since the ChIP technique measures an average across a population, it may be that 
discrepancies exist due to multiple infected cell types or states of latency in vivo, while the more 
uniform cell culture infection gives a different average association of acetylated histones with 
viral genomes.  More study on the consequences of structural changes to viral chromatin upon 
reactivation is clearly needed. 
1.7 METHODS TO STUDY LATENCY AND QUIESCENCE 
Study of viral genome structure during latency has proved to be difficult.  Various viral mutants 
have been studied for their ability to establish and reactivate from latency (12, 13, 28, 104, 111, 
124, 163, 192, 232, 254).  Reactivation and viral shedding has been studied by stressing mice or 
using mice deficient in various aspects of the immune system (167, 185, 186).  Elucidating the 
structure of the latent genome requires sacrifice and dissection of the animal, followed by 
biochemical analysis. 
As with all model systems, there are a number of drawbacks to studying latency in vivo.  
Changes may occur in viral genome structure during the manipulation of the animal and its 
dissected cells.  The act of explantation can itself reactivate latent virus (120, 233).  Additionally, 
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dissection of the TG does not isolate neuronal cells; various support cells are necessarily 
included when harvesting the TG, and it is difficult to isolate specific cell types in high enough 
purity to use for biochemical analysis. 
In order to overcome these limitations, cell culture models of HSV latency, known as 
quiescence, have been developed.  Cell culture models offer a number of advantages in the study 
of quiescence.  Primarily, they confer the ability to study the state of the genome in a uniform 
cell type.  They also bypass difficulties in determining the quantitative establishment of infection 
that may be due to varied infection efficiency, immune responses, or scarification of the eye.  
Cell culture techniques also allow for study of cells in the absence of an immune system, 
allowing a focus on innate cellular mechanisms of viral expression and control.  
Various cell culture systems have been used to study HSV quiescence including 
explanted mouse and rat neuronal cultures, which include support cells (228, 246, 266, 270-274); 
neuronally derived cell lines (101, 122, 132, 178, 253); rat-derived phaeochromocytoma (PC12) 
cells, which are thought to mimic the behavior of neurons, (11, 37); and even isolated human 
fetal neurons (267).  More exotic model systems have also been used, such as T-lymphoid lines 
(87, 88) and three dimensional keratinocyte cultures (241).  
The most extensively utilized human cell culture system for the study of quiescence has 
been human fibroblasts, generally of fetal origin.  These cells offer the advantage of being 
human in origin, thus having a vast array of compatible reagents available.  Primary fibroblasts 
also provide a uniform cell culture to study mechanistic details of quiescence and are amenable 
to quiescent infection, possibly due to their low metabolic rate (which may make them more 
similar to neurons than immortalized cell lines) or intrinsic factors that suppress lytic infection 
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(89, 168).  Fibroblasts are more repressive to gene expression in the absence of the viral 
transactivating protein ICP0 than most immortalized cell lines (246).  
The use of fibroblasts to support quiescent wild-type infection has required elevated 
temperature (34, 35, 98, 162, 181, 199, 261, 262); serum starvation (162); viral irradiation prior 
to infection (179); treatment with inhibitors of replication (30, 31, 181, 217, 268, 269), interferon 
(199, 217, 269), or various other chemicals (225).  Additionally, many of these techniques 
required infection at low multiplicity of infection (92, 208, 282), limiting the sensitivity of 
various assays. 
An alternative to the above techniques has been the use of viral mutants lacking essential 
genes to establish quiescent infection.  These mutants allow high multiplicity infection of cells, 
establishment of quiescence, and reactivation of expression or replication through the provision 
of one or more complementing genes in trans.  Mutants of VP16 are reduced in the ability to 
activate expression from IE genes (93, 110, 170, 199).  ICP4 is required to activate E and L 
genes (209).  ICP27, like ICP4, is essential for virus replication.  ICP0, though not absolutely 
required for viral replication, is a promiscuous transactivator of gene expression, and is required 
for efficient replication in a MOI and cell-type dependent manner (53, 96, 209).  Many viral 
systems used to establish quiescent infection contain lesions in multiple genes (60, 96, 170, 198, 
211, 212). 
Cell culture systems have advanced the understanding of HSV genetics and cellular 
mechanisms that regulate viral gene expression and replication, and have allowed for a 
mechanistic study of quiescence.  Viruses deficient in ICP0 necessarily cause deletions or 
truncations of LAT (206).  Since LAT is the predominant mRNA expressed by latent virus in 
vivo, this is a major drawback to such systems.  The true test of any model system, however, is 
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its ability to mimic in vivo, physiologically relevant situations.  Viral mutants have been used to 
establish latency in animal systems (28, 158, 232, 254), and viral mutant infection of fibroblasts 
have mimicked key aspects of latency and reactivation, establishing the use of cell culture 
systems as a valid system to investigate quiescent genomes.  
1.8 RATIONALE 
Due to the complications inherent in studying latency and genome structure in a complex animal 
system, cell culture techniques to investigate quiescence have been developed, and provide a 
robust, if imperfect, model for latency.  Models of quiescence give insight into the cellular 
mechanisms involved in viral transcriptional repression, as well as epigenetic control of gene 
transcription generally.  The epigenetic structure of the HSV genome is intimately linked to the 
establishment, maintenance, and reactivation from, quiescence.  Circular forms of the genome 
are more stable in cell culture, and are the predominant form of the genome found during in vivo 
latency. 
Shortly after infection and during entry into quiescence, the HSV genome becomes 
associated with histones.  These histones are modified with epigenetic marks of heterochromatin, 
including hypoacetylation of histones H3 and H4, hypomethylation of H3K4, and methylation of 
H3K9 on lytic gene promoters.  The kinetics of acquisition of these modifications vary between 
viral strains, mutants of specific viral genes, culture conditions, and cell type.  As establishment 
of quiescence proceeds and increasing repression of expression occurs, the viral genome is 
further packaged into a higher order chromatin structure, at least partially due to the association 
of HP1 with methylated H3K9.  The LAT promoter appears to maintain euchromatic 
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modifications in animal models, due to the presence of a chromatin boundary element.  It is 
probable that other proteins involved in the formation of higher-order chromatin structure, as 
well as other chromatin modifying proteins are associated with the quiescent genome.  More 
work is needed to fully elucidate the structure and maintenance of quiescent HSV. 
Reactivation provides insight into how the epigenetic structure of the viral genome is 
related to increased gene expression, as well as to the state of the genome before reactivation.  
The state of viral epigenetic repression varies between cell types, and likely even between cells 
of the same type.  The extent of heterochromatin may even vary between repressed genomes in 
the same cell.  Upon reactivation, quiescent genomes undergo structural changes, including a 
decrease in HP1 association and methylation of H3K9, and a corresponding increase of 
hyperacetylation at lytic promoters.   
HSV-1 reactivation from the latent state occurs during increased physical or emotional 
stress in an infected host (14) or following loss of immune function (215).  Efficient reactivation 
from latency requires the IE protein ICP0 (135).  ICP0 is a 775 amino acid protein (189) that is a 
promiscuous transactivator of gene expression.  It does not bind DNA, but rather causes an 
increase in transcription by interfering with host cell pathways ranging from the DNA damage 
response, the interferon response, and the cell cycle.  ICP0 is a critical viral protein that 
influences viral chromatin structure and host cell metabolism through multiple mechanisms.  
Therefore, we propose to characterize the histone modifications induced by ICP0, the 
mechanisms by which ICP0 causes these effects, and the structural motifs of ICP0 necessary for 
these effects.   
In order to facilitate studies of the chromatin changes induced by cell type and ICP0 
expression upon the entry into viral quiescence, the viruses d109 and d106 will be used.  d109 is 
 31 
a viral mutant that is defective for all five IE genes and expresses GFP under control of the 
hCMV promoter.  d106 expresses ICP0 and the GFP transgene, but none of the other IE proteins.  
Infection of either Vero or HEL cells, followed by RT-PCR, ChIP, or micrococcal nuclease 
digestion will give insight into the role of chromatin structure and its effect on viral gene 
expression during the establishment of quiescence. 
 
 
 
 
Figure 2.  Structure of the wild-type HSV-1 genome and the mutants d109, d106, and d105. 
The unique long (UL) and unique short (US) segments of the genome are flanked by inverted repeats: the long and 
short terminal repeats (TRL and TRS), and the long and short internal repeats (IRL and IRS).  The location of deleted 
IE genes is shown, as well as the inserted GFP transgene cassette, and the representative E and L genes tk and gC. 
 
 
 
d109 establishes long-term quiescence in cell culture, and gene expression from d109 can 
be reactivated by supplying ICP0 in trans, modeling reactivation from latency.  Quiescence will 
be established with d109, and gene expression will be reactivated by providing ICP0 in trans by 
superinfection with various viruses and mutants of ICP0.  By modeling reactivation with the 
virus d105, which is an isogenic variant of d106 that does not contain the GFP transgene 
cassette, the kinetics of chromatin changes and reactivation of gene expression will be measured 
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by RT-PCR, ChIP and micrococcal nuclease digestion.  Adenovirus vector AdS.11E4(ICP0) 
expresses ICP0, and AdS.10, its parent vector, does not (96).  Superinfection by these vectors, 
followed by RT-PCR and ChIP, will be used to establish the epigenetic effects of ICP0 on 
reactivating quiescent genomes in the absence of other HSV-1 proteins. 
In order to characterize the effects of the various functional domains of ICP0 on the 
chromatin structure and gene expression of reactivating quiescent d109, various mutants of ICP0 
will be used to superinfect cells quiescently infected with d109.  n212 expresses all of the IE 
genes except ICP0, and does not contain the GFP transgene (23). The RF mutant contains point 
mutations that inactivate the RING finger domain (146).  R8507 contains point mutations in the 
C-terminus of ICP0 that abrogate its ability to disrupt the CoREST repressor complex (83).  The 
wild-type (wt) strain of virus used will be KOS.  Following superinfection, RT-PCR and ChIP 
will be performed. 
These studies will give insight into the epigenetic mechanisms used by cells to suppress 
gene expression from incoming viral DNA, and the viral strategy used to counteract this cellular 
defense.  If the underlying epigenetic mechanisms of HSV-1 establishment of, and reactivation 
from, latency can be understood, it may provide new targets for therapy and prevention of 
symptomatic HSV-1 infection.  Additionally, this research will give greater insight into 
mechanisms of epigenetic transcriptional control, which has implications in many diseases, 
including infectious diseases and cancer (47). 
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Figure 3.  Functional domains attributed to ICP0, and ICP0 mutants RF, R8507, and R8508. 
ICP0 is a 775 amino acid protein composed of 3 exons.  Shown are the amino acids attributed to each reported 
function and interaction (above ICP0) and the point mutations in the ICP0 mutants RF (146), R8507 (83), and 
R8508 (83), used in chapter 4 (below ICP0).   The studies determining each domain are as follows: RING finger (52, 
68, 69), BMAL 1 interaction (115), Cyclin D3 interaction (257), CoREST homology (78) and binding (81), Nuclear 
Localization Sequence (173), ND10 Localization (160), Homodimerization domain (27), EF-1δ interaction (114), 
ICP4 interaction (27), USP7 interaction (58), ICP27 interaction (283). 
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2.0  EPIGENETIC MODULATION OF GENE EXPRESSION FROM QUIESCENT 
HSV GENOMES 
2.1 ABSTRACT 
The ability of herpes simplex virus to persist in cells depends on the extent of viral gene 
expression, which may be controlled by epigenetic mechanisms.  We used quiescent infection 
with the viral mutants d109 and d106 to explore the effects of cell type and the presence of the 
viral protein ICP0 on the expression and chromatin structure of the human cytomegalovirus 
(HCMV), tk, and gC promoters on the viral genome.  Expression from the HCMV promoter on 
the d109 genome decreased with time and was considerably less in HEL cells than in Vero cells.  
Expression from the HCMV promoter in d106 was considerably more abundant than in d109, 
and this increased with time in both cell types.  The same pattern of expression was seen on the 
tk and gC genes on the viral genomes, although the levels of tk and gC RNA were approximately 
102- and 105-fold lower than those of wild-type virus in d106 and d109, respectively.  In 
micrococcal nuclease digestion experiments, nucleosomes were evident on the d109 genome, 
and the amount of total H3 as determined by chromatin immunoprecipitation was considerably 
greater on d109 than d106 genomes.  The acetylation of histone H3 on the d106 genomes was 
evident at early and late times postinfection in Vero cells, but only at late times in HEL cells.  
The same pattern was observed for H3 acetylated on lysine 9.  Trimethylation of H3K9 on d109 
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genomes was evident only at late times postinfection in Vero cells, while it was observed both 
early and late in HEL cells.  Heterochromatin protein 1γ (HP1γ) was generally present only on 
d109 genomes at late times postinfection of HEL cells.  The observations of chromatin structure 
correlate with the expression patterns of the three analyzed genes on the quiescent genomes.  
Therefore, several mechanisms generally affect the expression and contribute to the silencing of 
persisting genomes.  These are the abundance of nucleosomes, the acetylation state of the 
histones, and heterochromatin.  The extents to which these different mechanisms contribute to 
repression vary in different cell types and are counteracted by the presence of ICP0. 
2.2 INTRODUCTION 
Early in productive infection, the herpes simplex type 1 (HSV-1) genome becomes bound with 
what appears to be an irregular arrangement histones, and the presence of nucleosomes has not 
been established (95, 96, 117, 136, 172).  In contrast, nucleosomes have been found associated 
with latent HSV-1 genomes (110), as well as, possibly, heterochromatin (43).  During latency 
there is little to no viral gene expression, with the predominant expressed gene being that for the 
latency-associated transcript, or LAT (230, 231).  This suggests a general repression of 
transcription, probably as a result of epigenetic mechanisms.  DNA methylation is probably not 
the major means of control of HSV-1 gene expression because latent HSV-1 DNA is not 
extensively methylated (19, 128).  In contrast, a number of studies have implicated chromatin 
structure and specific histone tail modifications in the control of HSV-1 latency, reactivation, 
and replication (1, 20, 117, 128, 255, 259).  Thus, histone association and chromatin structure 
 36 
during the early stages of infection is likely to be involved in determining the extent of viral gene 
expression, and hence, whether productive or latent infection ensues (119). 
Expression of ICP0 during this initial phase of infection may play a major role in 
determining which type of infection HSV-1 undergoes.  ICP0 colocalizes with, and causes the 
disruption of, ND10 bodies, which are discrete multiprotein nuclear structures (16, 65, 79, 160). 
The RING finger ubiquitin ligase domain of ICP0 mediates the proteasomal degradation of the 
promyelytic leukemia (PML) and Sp100 proteins, which are components of ND10 domains (79).  
The heterochromatin-binding protein HP1 interacts with Sp100, and can also be found at 
centromeres, forming a link between the disruption of ND10 bodies and chromatin (49).  ICP0 
also mediates the degradation of the centromere-associated proteins CENP-A  (152) and CENP-
C (55) in a proteasome-dependent manner.  CENP-A is a histone H3-like centromere core 
protein thought to be involved in the assembly of heterochromatin (240).  CENP-C also interacts 
with pro-apoptotic proteins, so degradation of CENP-C may be a viral mechanism to inhibit 
apoptosis, as well as to disrupt heterochromatin (191).   
 ICP0 also leads to the disruption of several transcriptionally repressive protein 
complexes.  The C-terminal amino acids 537 to 613 of ICP0 share significant homology with a 
segment of CoREST (78).  Histone deacetylases (HDACs) 1 and 2 form a complex with the 
REST and CoREST repressors of gene expression in nonneuronal cells.  ICP0 binds the 
REST/CoREST/HDAC1/2 complex and causes the dissociation of HDAC1/2.  CoREST and 
HDAC1/2 are then phosphorylated by HSV-1 proteins independently of ICP0 and translocated to 
the cytoplasm (78).  This mechanism may provide for the specific derepression of certain cellular 
and viral genes.  ICP0 also interacts with class II HDACs 4, 5, and 7 (153).  Class II HDACs are 
found in multiprotein complexes with transcriptional repressors (258).  HDACs 4, 5, and 7 are 
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involved in developmental pathways in neurons, and it has been hypothesized that ICP0 inhibits 
their repressive activity in order to promote neuronal survival during productive infection (153).  
Additionally, herpesviral homologs of ICP0 interact with HDACs (281).   
HDAC inhibitors have also been shown to reactivate gene expression from quiescent 
genomes (97, 246).  Quiescent infections of standard tissue culture cells with HSV-1 can be 
established using mutants defective in multiple genes that activate HSV gene expression or affect 
host cell metabolism (60, 96, 170, 196, 198, 211, 212).  Trichostatin A (TSA) can activate the 
otherwise repressed expression from the human cytomegalovirus (HCMV) promoter on 
quiescent genomes similarly to ICP0 in Vero cells prior to 24 hours post infection (p.i.) (246).  
However, at 7 days p.i., reactivation induced by TSA is significantly decreased compared to 
ICP0-mediated reactivation.  These effects were also seen in neuronal cultures, with support cells 
even more poorly reactivated than neurons (246).  Importantly, TSA poorly activates gene 
expression from quiescent genomes in primary human fibroblasts, even when added at the time 
of infection (62), suggesting there exist repressive functions other than histone deacetylation that 
ICP0 can abrogate.  Additionally, this higher order repression seems to be cell type dependent.  
Therefore, there may be multiple mechanisms by which ICP0 mediates the derepression of the 
viral genome. 
Our laboratory has been examining the characteristics two viral mutants, d109 and d106 
(211), as a model for some of the events that occur very early in infection or during latency in 
vivo.  d109 is a viral mutant defective for all five immediate early (IE) genes.  It expresses freen 
fluorescent protein (GFP) under control of the HCMV IE promoter and establishes a persistent 
quiescent infection in several cell types, including Vero and HEL cells and primary trigeminal 
neurons (211).  It is nontoxic to these cells and the viral genome persists in a quiescent state in 
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the cells for prolonged periods of time.  This is similar to other quiescent systems that are based 
on the inactivation of multiple viral activators (60, 96, 170, 196, 198, 211, 212).  d109 can be 
reactivated from quiescence by supplying ICP0 in trans.  d106 expresses ICP0 and the GFP 
transgene, but none of the other IE proteins (211).  We used this system to investigate the 
epigenetic state of quiescent viral genomes at three different loci as a function of time after 
infection, cell type, and the presence of ICP0.  This was compared to the level of expression of 
genes at these loci.  Our results suggest that the expression of the loci is generally influenced by 
multiple levels of epigenetic regulation that also quantitatively differ in different cell types.  The 
expression of ICP0 resulted in the reduction of the number of histones on the genome, as well as 
in the extent of modifications that promote higher order chromatin structure. 
2.3 MATERIALS AND METHODS 
2.3.1 Cells and viruses 
Experiments were performed using Vero cells (African green monkey kidney cells) or HEL 
(human embryonic lung) cells from the American Type Culture Collection (ATCC) and 
propagated as they recommended.  The viruses used in this study were the wild-type (wt) HSV-1 
(KOS), which was propagated on Vero cells, and IE mutants d106 and d109 (211).  d106 was 
propagated on E11 cells and d109 on F06 cells as previously described (211). 
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2.3.2 ChIP 
Chromatin immunoprecipitation (ChIP) analysis was carried out as previously described (213) 
with a few modifications.  Vero or HEL cells (5 x 106) were plated in 100-mm dishes, and were 
infected by either d109 or d106 at a multiplicity of infection (MOI) of 10 at 4°C for 1 hour with 
rocking every 10 minutes.  After adsorption, the inoculum was aspirated and 37°C 5% 
Dulbecco’s modified Eagle’s medium was added.  This was considered 0 hours p.i.  At 4 and 24 
hours p.i., the cells were treated with 1% formaldehyde for 10 minutes at 37°C, washed 3 times 
with cold phosphate-buffered saline containing protease inhibitors (67 ng/ml aprotinin, 1 ng 
pepstatin, 0.16 mM TLCK [Nα-ptosyl-L-lysine chloromethyl ketone], 1 mM 
phenylmethylsulfonyl fluoride [PMSF]).  The cells were pelleted at 3,000 rpm for 10 minutes at 
4°C and resuspended in cold PIPES [piperazine-N,N’-bis(2-ethanesulfonic acid] lysis buffer (100 
µl per million cells) containing protease inhibitors (5 mM PIPES, 85 mM KCl, 0.5% NP-40, 4 
µg/ml aprotinin, 2 µg/ml pepstatin, 0.15mMTLCK, and 0.6mMPMSF), and incubated on ice for 
15 min.  The antibodies used were anti-histone H3 (Abcam; ab1791), anti-acetyl histone H3 
(Millipore; 06-599), anti-acetyl histone H3 lysine 9 (Millipore; 07-352), anti-trimethyl histone 
H3 lysine 9 (Millipore; 07-442), and anti-heterochromatin protein 1γ (Millipore; 05-690).  A “no 
antibody control” was included for each ChIP experiment.  When calculating ChIP results after 
quantitative PCR (qPCR), the value for the no-antibody control was subtracted from the 
immunoprecipitation results before the percent input of immunoprecipitation was calculated.  
Therefore, any values reported indicate an increase over the baseline.  The baseline, or no-
antibody control, was always considerably less than the results for the specific 
immunoprecipitations.  In addition, the analysis was also performed on mock-infected cells to 
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control for possible external contamination.  All other procedures were as described previously 
(213). 
2.3.3 Micrococcal nuclease digestion 
Vero or HEL cells (2 x 107) were infected at an MOI of 20 PFU/cell with d109 or d106.  Nuclei 
were isolated at the indicated time points, divided into 4 aliquots, and digested with 20 units 
micrococcal nuclease (MN) for 2, 10, or 30 minutes.  DNA was isolated by phenol chloroform 
extraction and ethanol precipitation and separated on a 2% agarose gel, transferred to Nytran 
membrane, probed with 32P-labeled nick-translated HSV bacterial artificial chromosome (BAC) 
DNA (obtained from David Leib, Washington University), and exposed to Hybond film. 
2.3.4 RNA isolation and reverse transcription 
RNA was isolated with the Ambion RNaqueous -4PCR kit, following the included protocol.  
Briefly, 5 x 106 Vero cells or 7.5 x 106 HEL cells in 100-mm plates were infected at an MOI of 
10 by d109, d106 or KOS at room temperature.  RNA was harvested at the indicated time points 
by adding 500 μl lysis buffer, provided in the kit.  The cells were scraped and vortexed.  An 
equal volume of 67% ethanol was added, and the mixture was added to a filter, which was 
centrifuged at 12,500 rpm at 4°C for 1 min.  The bound RNA was washed with wash buffers 1 
and 2/3.  RNA was eluted with 60 μl 65°C elution solution.  The RNA was treated with DNase I 
at 37°C for 30 min to degrade any residual DNA. 
Reverse transcription was performed using the Ambion reverse transcription kit and 
following the included instructions.  Total RNA (2 μg) was reverse transcribed in a reaction 
 41 
volume of 20 μl containing RNase inhibitor, oligo(dT) primers 1 μl Moloney murine leukemia 
virus reverse transcriptase (RT) and 2 μl 10x reaction buffer.  The reaction tube was incubated at 
85°C for 5 minutes to remove RNA secondary structure, and the reverse transcription reaction 
was carried out for 1 hour at 44°C.  After the reverse transcription reaction was complete, the 
reaction tube was incubated at 95°C for 10 minutes in order to inactivate the RT.  8 μl of cDNA 
was diluted 1:6 by adding 40 μl DNase/RNase-free H2O for use in qPCRs.  Additionally, 1 μg 
RNA was diluted into a total of 60 μl DNase/RNase-free H2O for use as a negative control in 
qPCRs. 
2.3.5 Real-time PCR 
Reactions for ChIP or cDNA quantification were performed in triplicate using 5 μl of DNA for 
each reaction as described previously (213), with a few modifications.  Before the 96-well 
reaction plate was set up, a master mix containing 0.625 μl of each primer (stock concentration, 1 
mM), 12.5 μl Applied Biosystems SYBR green super mix with 1.0 μM 6-carboxy-X-rhodamine 
(Bio-Rad), and 6.25 μl of water for a total of 20 μl for each reaction was made.  The final 
reaction volume was 25 μl, including the DNA.  The primers used for ChIP and cDNA 
quantification and their locations relative to the transcription start site of the gene to be analyzed 
are given in Table 1.  d106 DNA was also included in each plate, in a standard curve of 1:10 
dilutions from 500,000 to 50 copies per well, which covers the threshold cycle values for the 
ChIP DNA samples tested.  qPCR was run on a ABI 7900HT Fast Real Time machine.  The 
conditions for the run were as follows: stage 1, 50°C for 2 min; Stage 2, 95°C for 10 min; and 
stage 3, 40 cycle repeats of 95°C for 15 seconds and 60°C for 1 min.  At the end of the run, a 
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dissociation curve was completed to determine the purity of the amplified products.  Results 
were analyzed using the SDS 2.3 software from Applied Biosystems. 
 
Table 1.  Primers used for RT-PCR. 
Primer Sequence Position relative to 
transcription start site
 
tkproma CAGCTGCTTCATCCCCGTGG 
AGATCTGCGGCACGCTGTTG
-200 to +56 
tkds1b ACCCGCTTAACAGCGTCAACA 
CCAAAGAGGTGCGGGAGTTT
+15 to +84 
gCproma CGCCGGTGTGTGATGATTT     
TTTATACCCGGGCCCCAT
-84 to -26 
gCds1b GGGTCCGTCCCCCCCAAT    
CGTTAGGTTGGGGGCGCT
+627 to +735 
HCMVproma CATCTACGTATTAGTCATCGCTA 
TTACTGGAAATCCCCGTGAGTCA
-249 to -156 
GFPds1b GTCGTGCTGCTTCATGTG     
AGTTCATCTGCACCACCG
+166 to +278 
 
 a Promoter sequence. 
 b Downstream in mRNA. 
2.4 RESULTS 
2.4.1 RNA expression from quiescent genomes 
GFP is abundantly expressed from the HCMV promoter on the d106 genome, whereas GFP is 
only abundantly expressed in a subpopulation of d109-infected cells (211, 246).  An aim of this 
study is to examine the effects of epigenetic state on the expression of viral genes.  Therefore, it 
was of interest to determine how the physical state of chromatin on the HCMV promoter 
correlates with the expression of GFP.  It was also of interest to examine the expression of genes 
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distant from the strong HCMV promoter, to determine the generality the epigenetic mechanisms.  
With the exception of ICP6 on d106 (211), the remaining HSV promoters on the d109 and d106 
genomes are poorly expressed due to the absence of ICP4.  However, transcription of early and 
late genes in the absence of ICP4 is detectable (212, 279).  This is a consequence of cellular 
transcription factors functioning in the absence of viral regulators.  Real time PCR was used to 
quantify the levels of GFP (HCMV promoter driven), tk (an early gene) and gC (a late gene) 
mRNAs in d109- and d106-infected Vero and HEL cells at 4 and 24 h p.i.  The levels of these 
transcripts in wt-virus-infected cells at 2, 4, and 8 h post infection were also quantified for 
comparison.  The abundance of GFP mRNA detected in KOS infected cells was less than 103 
molecules/ug RNA, whereas it was as much as 2.3 x 109 molecules/ug of mRNA in d106-
infected Vero cells (Figure 4).  Therefore the levels of mRNA molecules measured in this 
experiment differed by approximately 6.5 orders of magnitude.   
The amounts of GFP mRNA in d106-infected Vero cells were 2.5- and 30- fold more 
abundant than in d109-infected cells at 4 and 24 h, respectively.  These differences were 14- and 
360-fold in HEL cells at 4 and 24 h, respectively.  Therefore, GFP expression in d109-infected 
cells decreased with time and was lower in HEL than in Vero cells.  This is indicative of 
repression in the absence of ICP0, which becomes more restrictive over time and is possibly 
more pronounced in HEL cells than in Vero cells.  At 4 h p.i., the levels of tk and gC RNA in 
cells infected with d106 and d109 were approximately 102- to 103- and 103- to 104-fold lower 
than in wt-virus-infected cells, respectively.  In addition, depending upon the cell type and time 
p.i., the numbers of tk and gC mRNAs present in d106- and d109- infected cells were 
approximately 103 to 104 less than those of GFP mRNA.  However, the same pattern of 
expression seen for GFP, and described above, was also seen for the tk and gC genes.  Therefore, 
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despite the large difference in expression between the activity of HCMV IE promoter and those 
driving expression of the tk and gC in d109- and d106- infected cells, similar mechanisms appear 
to affect the expression of all three genes. 
 
 
 
 
Figure 4.  Abundance of GFP, tk, and gC mRNAs in KOS-, d109-, and d106-infected Vero and HEL cells. 
Infections, RNA isolation, cDNA preparation, and RT-PCR with primer sets for the indicated mRNAs were 
performed as described in Materials and Methods. The procedure for creating standard curves for quantification 
using the indicated primers is also described in Materials and Methods. The graphs indicate the number of RNA 
molecules of each gene per µg RNA at the indicated time points (2, 4, 8, and 24 h p.i.) in Vero and HEL cells. 
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2.4.2 Histone deposition on the viral genome as a function of cell type and ICP0 
Following entry at the plasma membrane, the nucleocapsid is transported to the nucleus, 
where the genome is inserted.  Histones can be found on the viral genome early after infection 
(117, 183), and quiescent genomes are associated with histone H3 through day 6 p.i. (32).  HSV-
1 gene products most likely affect histone deposition on the genome.  Both VP16 and VP22 have 
been reported to decrease histone deposition on the viral genome (95, 255).  The activities of 
ICP0 are also consistent with effects on chromatin structure (55, 78, 80, 81, 152, 153, 195, 246).  
As a first step towards determining the epigenetic mechanisms that contribute to the expression 
profile observed in Figure 4, two approaches were employed.  The first examined the 
nucleosomal structure of the viral genome by MN analysis of nuclear DNA.  The second is to 
quantify the amount of total histone H3 on the viral genomes. 
Vero and HEL cells were infected with d109 and d106.  At 4 and 24 h p.i. nuclei were 
prepared and subjected to MN analysis.  The nuclei were incubated with MN for increasing 
lengths of time.  The DNA was then isolated, run on an agarose gel, blotted onto nylon and 
probed with 32P-labeled HSV sequences.  Figure 5 shows both the ethidium bromide (EtBr) 
stained gel prior to blotting and the autoradiographic images of the exposed probed blot.  The 
nucleosomal banding pattern of the bulk cellular DNA is clearly evident in the EtBr stained gels 
of both cell types.  The Southern blot was probed with purified 32P-labeled HSV DNA contained 
in a BAC.  Therefore, the observed pattern represents the sum of possibly different patterns from 
different regions of the genome.  However, a similar pattern was seen when the HCMV IE 
promoter was used as a probe (unpublished observations).  A reproducible nucleosomal 
hybridization pattern was evident, particularly in d109-infected HEL cells (Figure 5A); however, 
the pattern was more heterogeneous than the EtBr pattern observed for the bulk cellular DNA.  
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Therefore, the chromatin on the d109 genome in HEL cells may be more organized.  However, 
there are portions or populations of d109 genomes in HEL and Vero cells that result in a 
heterogeneous MN pattern. Nucleosomal structure was not reproducibly observed on d106 
genomes in HEL or Vero cells. The observed heterogeneous pattern might have been due to less 
ordered nucleosomal structure, or despite the fact that only nuclei were subjected to the analysis, 
some of the genomes might still have been in capsids bound to the nuclei. None of the observed 
hybridization pattern was due to cross-hybridization to the cellular DNA, since mock-infected 
cell lanes were clear.  
Another approach to probe the possible association of nucleosomes with the genomes is 
to determine the amount of bulk histone, in this case H3, by ChIP analysis.  Vero and HEL cells 
were infected with d109 or d106, and at 4 and 24 h p.i. were subjected to ChIP analysis using an 
antibody against H3 (Figure 6).  The extent of sequences in the immunoprecipitate was 
determined by real-time PCR.  In HEL cells (Figure 6B), association of histone H3 with all three 
promoters on d109 could be seen at 4 h p.i. and increased by 24 h p.i.  In contrast, the association 
of histone H3 with d106 is greatly reduced and never rose above a low level.  A similar pattern 
of histone association occurs in Vero cells, except that the histone H3 association with the tk 
promoter of d109 only marginally increased from 4 to 24 h p.i.   
The results of the ChIP (Figure 6) and the MN (Figure 5) assays are consistent in that 
they suggest greater nucleosomal association with the d109 than the d106 genome.  The increase 
in H3 on the d109 genome (Figure 6) is also consistent with the decreased expression from d109 
genome at 24 h p.i. (Figure 4).  The reduced amounts of H3 on the viral genome during d106 
infection are consistent with the greater expression of the d106 genome (Figure 4), and possibly 
indicative of interference in histone deposition by ICP0.  
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 Figure 5.  MN digestion of d109- and d106-infected cells. 
Nuclei were isolated from d109-, d106-, or mock-infected HEL cells (A) or Vero cells (B) and digested with 20 
units MN for 2, 10, or 30 min. The DNA was isolated from the nuclei at 4 and 24 h p.i., purified, and fractionated on 
2.0% agarose gels. The agarose gels were stained with EtBr (top) and transferred to Nytran membranes for Southern 
blot hybridization as described in Materials and Methods. The Southern blots (bottom) were probed with 32P-
labeled HSV BAC DNA, washed, and exposed to X-ray film. Shown are the autoradiographic images of the probed 
blots (bottom). 
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Figure 6.  Binding of histone H3 to the tk, gC, and HCMV promoters of d109 and d106 in Vero and HEL 
cells. 
 
ChIP with an antibody to histone H3 and RT-PCR with primer pairs corresponding to the indicated promoter regions 
were performed as described in Materials and Methods. The graphs show the percentages of total genomes bound at 
4 and 24 h p.i. in Vero cells (A) and HEL cells (B). The error bars represent standard deviations from multiple 
experiments. 
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2.4.3 Acetylation of histone H3 on quiescent viral genomes is a function of ICP0 
Histone H3 hyperacetylation (AcH3) is associated with increased transcriptional activity (221).  
Lytic infection has been shown to increase global cellular levels of acetylated histone H3 (117), 
and ICP0 has been implicated in increasing the acetylation of histones on the viral genome (29, 
32).  ICP0 has also been shown to inhibit repressive complexes that include HDACs (78, 82).  
Additionally, HDAC inhibitors, such as TSA, have been shown to increase HSV-1 expression 
and to derepress HSV quiescence in a manner similar to ICP0 in Vero cells (97, 246).  
ChIP was used to determine the extent of AcH3 on the d109 and d106 genomes in Vero 
and HEL cells.  In Vero cells, AcH3 was low on all the promoters on the d109 genomes, but was 
elevated on d106 genomes at both 4 and 24 h p.i. (Figure 7A).  The extent of H3 acetylation in 
d106-infected cells is masked by the fact that there is less total H3 on the genomes.  This is 
clearly seen when the amount of AcH3 is divided by the total H3 (Figure 7C).  Therefore, while 
the amount of AcH3 on the HCMV promoter is not very much greater than in d109-infected 
cells, the H3 that is on the d106 genomes is more extensively acetylated.  The same general 
pattern was observed in HEL cells (Figure 7B and D), although the amounts and fraction of 
AcH3 on the promoters in d106-infected cells were not as elevated relative to d109 as it was in 
Vero cells.  This is consistent with the lower level of expression in HEL cells. 
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Figure 7.  Binding of AcH3 to the tk, gC, and HCMV promoters of d109 and d106 in Vero and HEL cells. 
ChIP with an antibody to AcH3 and RT-PCR were performed as described in the legend to Figure 6 to determine the 
percentages of genomes bound by AcH3 at 4 and 24 h p.i. in Vero (A) and HEL (B) cells. The error bars represent 
standard deviations from multiple experiments. In order to compensate for the reduced histone H3 on d106 
promoters, AcH3 was normalized to the amount of histone H3 on the genome by dividing the percentage of AcH3 
associated with each promoter by the percent histone H3 (Figure 6) in Vero cells (C) and HEL cells (D). 
 
 
 
To further investigate the effects of cell type and ICP0 on the acetylation state of histones 
associated with quiescent genomes, we performed ChIP for acetylated histone H3 lysine 9 
(H3K9Ac) (Figure 8).  This specific modification has been associated with increased 
transcription.  This may be due to the loss of the positive charge of lysine and decreased 
electrostatic attraction of the histone tail to the DNA backbone, and/or it may increase 
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transcription by preventing histone H3 lysine 9 methylation (H3K9me), which is associated with 
a decrease in the rate of transcription. 
The amount of H3K9Ac on the promoters in d109-infected cells was relatively low 
(Figure 8A and B).  Also as shown in Figure 7, the exception is the HCMV promoter at 4 h p.i., 
where the amount of H3K9Ac was elevated relative to the other promoters in both cell types.  
The amount of H3K9Ac on the d106 genome was readily evident at 4 h p.i. in Vero cells (Fig 8A 
and C), whereas it was not in HEL cells but became detectable later in infection (Figure 8B and 
D).  Therefore, the pattern of H3K9Ac was similar to that of AcH3 on the tk, gC and HCMV 
promoters of d109 and d106 in both Vero and HEL cells. 
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Figure 8.  Binding of H3K9Ac to the tk, gC, and HCMV promoters of d109 and d106 in Vero and HEL cells. 
ChIP with an antibody to H3K9Ac and RT-PCR were performed as described in the legend to Figure 6 to determine 
the percentage of genomes bound by H3K9Ac at 4 and 24 h p.i. in Vero (A) and HEL (B) cells. The error bars 
represent standard deviations from multiple experiments. In order to compensate for the reduced histone H3 on d106 
promoters, AcH3 was normalized to the amount of histone H3 on the genome by dividing the percentage of AcH3 
associated with each promoter by the percent histone H3 (Figure 6) in Vero cells (C) and HEL cells (D). 
 
 
2.4.4 Effects of cell type and ICP0 on repressive chromatin structure 
The global repression of HSV during latency is likely due to epigenetic mechanisms.  Histone 
lysine methylation is associated with both activation and repression of transcription, depending 
on which residue is modified (8, 121).  These modifications may recruit additional proteins that 
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help to either silence or activate transcription.  Trimethylation of histone H3 lysine 9 (H3K9me3) 
is correlated with repression of expression (8).  Lysine methylation does not remove a positive 
charge from the histone tail and also precludes acetylation.  Additionally, histone lysine 
methylation is a very stable histone modification (202), which could help to form the basis of 
long-term quiescence.  H3K9me3 is a binding site for heterochromatin protein 1 (HP1) (5, 131, 
174), which helps to silence transcription and form higher order chromatin structure (134, 149).   
We investigated the presence of H3K9me3 and HP1γ by ChIP analysis (Figure 9).  
H3K9me3 was rarely found on the d109 genomes in Vero cells at 4 h p.i. or on the d106 
genomes in both HEL and Vero cells (Figure 9A and B).  In HEL cells, H3K9me3 was detected 
on all three promoters on the d109 genome at both 4 and 24 h p.i. (Fig 9B).  However, H3K9me3 
was detected on the gC and HCMV IE promoters only on the d109 genome in Vero cells at 24 h 
p.i. (Figure 9A).  HP1γ helps to form higher order chromatin structure, and binds to H3K9me3.  
The amounts of HP1γ binding to the HCMV, tk, and gC promoters of d109- and d106-infected 
HEL and Vero cells were determined by ChIP.  HP1γ was rarely found on the d109 genomes at 4 
h p.i. or on the d106 genome under any circumstances (Figure 9C and D).  In d109-infected Vero 
cells, HP1γ was only seen on the gC promoter at 24 h (Figure 9C), whereas it was detected on all 
three of the promoters in d109-infected HEL cells at 24 h (Figure 9D).  
Considering d109 infection, the general pattern that arises from the data of Figure 9 is 
that: i. H3K9 methylation precedes HP1γ association, ii. H3K9 methylation occurs more rapidly 
in HEL cells than in Vero cells, and iii. HP1γ association is only generally seen at 24 h p.i. of 
HEL cells.  These data are consistent with a more restrictive environment to gene expression 
from the d109 genome in HEL than in Vero cells (Figure 4).  Reduced amounts of H3K9 
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methylation and HP1γ deposition were consistently observed in d106-infected cells, suggesting a 
direct or indirect inhibitory effect of ICP0 on this repressive mechanism. 
 
 
 
 
Figure 9.  Repressive chromatin modifications associated with the tk, gC, and HCMV promoters of d109 and 
d106 in Vero and HEL cells. 
 
ChIP with antibodies to H3K9me3 (A and B) and HP1γ (C and D), followed by RT-PCR, was performed as 
described in the legend to Figure 6 to determine the percentages of genomes bound by H3K9me3 (A and B) and 
HP1γ (C and D) at 4 and 24 h p.i. in Vero (A and C) and HEL (B and D) cells. The error bars represent standard 
deviations from multiple experiments. 
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2.5 DISCUSSION 
The mutant virus d109 does not express HSV IE proteins and is subject to repression, where 
even the relatively potent HCMV IE promoter is only abundantly expressed in a subpopulation 
of infected cells.  d109 genomes persist in a quiescent state in most cell types.  Thus, aspects of 
the cellular mechanisms influencing quiescent genomes in culture may reflect HSV latency in 
animal models (43, 259).  In this study, ChIP was used to examine the states of chromatinization 
of three promoters with different relative activities and locations on quiescent viral genomes and 
to observe how this state may be affected by the expression of ICP0, and possibly differ in 
different cell types.  We examined the deposition of nucleosomes on the genomes, and focused 
on histone H3 with respect to its abundance on the genomes, acetylation (total and lysine 9) and 
methylation (lysine 9) states, and the presence of the heterochromatin protein, HP1γ.  The 
chromatinization state was correlated with the level of expression at the three analyzed loci. 
2.5.1 Gene expression as a function of IE proteins 
In the absence of the IE proteins ICP4, -27 and -22 (d106-infected cells), expression levels of the 
tk and gC loci were dramatically reduced relative to that seen in KOS-infected cells (Figure 4), 
largely due to the absence of ICP4, which is the major activator of early and late genes.  Unlike 
tk and gC, expression from the HCMV IE promoter was abundant in d106-infected cells.  This is 
presumably due to the presence of the strong enhancer in the HCMV IE promoter (235, 236, 
249).  The additional lack of ICP0 expression (d109) further lowered the expression of the 
HCMV IE, tk and gC promoters.  This was more pronounced at 24 h than at 4 h p.i., suggesting 
either an activation of expression in the presence of ICP0 or the active inhibition of transcription 
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in the absence of ICP0.  Expression was generally lower in HEL cells than in Vero cells.  In 
addition, the difference in the expression in the presence of ICP0 relative to expression in its 
absence was greater in HEL cells than in Vero cells.  This is consistent with a greater 
involvement of repression mechanisms functioning on the genome in HEL cells.   
2.5.2 Deposition of nucleosomes and histone H3 as a function of ICP0 
Nucleosomal structure as visualized by MN analysis was evident on d109 genomes, 
particularly in HEL cells (Figure 5).  It was less evident for d106 genomes.  However in both 
d106 and d109, there was a background of nuclease digestion products that was not consistent 
with an ordered nucleosomal structure.  Previous studies of wt HSV suggested that during 
productive infection there is little nucleosomal structure and that the genome may be more 
sensitive to MN digestion (136, 137).  The more heterogeneous component in the MN analysis in 
our studies may be similar to that observed in these previous studies.  However it is not entirely 
appropriate to compare wt infections to those analyzed in this study.  Unlike that of wt virus, the 
genomes of d106 and d109 are not replicating and are not being packaged.  In wt virus 
infections, these processes typically begin at 4 and 6 h, respectively, and undoubtedly influence 
the MN analysis.  A more appropriate comparison is a previous study by Jamieson et al. (110), 
which did not find an ordered nucleosomal structure on the tk promoter in cells infected with a 
mutant defective in VP16 and with restricted expression of ICP0 in the presence of alpha 
interferon.  The difference between our results and these may be the extent of IE gene 
inactivation in the two systems.  Alternatively, there may be little difference at all.  In both 
studies, the analysis was complicated by the fact that not all infecting genomes are exposed to 
the cellular machinery in the nucleus.  The previous study hypothesized that many of the 
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genomes did not uncoat, for example.  In addition, while the entire HSV-1 genome was used as a 
probe in Figure 5, the use of promoter-specific probes revealed little difference from the results 
in Figure 5 (unpublished observations). 
As an alternative approach to examining possible nucleosomal deposition on quiescent 
genomes, the abundance of bulk histone H3 was determined by ChIP analysis (Figure 6).  The 
expression of ICP0 resulted in the decreased association of H3 at all three promoter loci in both 
HEL and Vero cells (Figure 6).  Therefore, the presence of ICP0 somehow prevents the 
association of histone H3 with the genome.  The reduced association of H3 in the presence of 
ICP0 is probably not a function of transcription, since the amount of H3 on the tk and gC 
promoters is comparable to that on the HCMV IE promoter in d106-infeted HEL cells, despite 
the observation that the tk and gC promoters are 2 to 3 orders of magnitude less transcriptionally 
active than the HCMV IE promoters (Figure 4).   
A recent study by Coleman, et al. (32) investigated H3 association with quiescent 
genomes upon reactivation from quiescence, and found that although hyperacetylation of the 
histones bound to the viral genome occurred upon the expression of ICP0, the total amount of 
bound histone H3 remained constant upon reactivation.  This indicates that ICP0 does not 
facilitate the removal of histones from the viral genome.  Our study, in which ICP0 is expressed 
from the outset of infection, suggests that it is able to prevent the deposition of histone H3 onto 
all three types of viral promoters.  This is consistent with a study showing that ICP0 prevented 
the binding of H3 to the genome during productive infection (29).  This may occur by 
relocalization or degradation of histones or histone chaperones, which subsequently leads to a 
more open viral genome configuration in which the availability of transcription factors can 
control expression, unimpeded by epigenetic structure.   
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ICP0 causes increased acetylation of histone H3 bound to the viral genome (32).  ICP0 
interacts with and causes the relocalization of class II HDACs (153).  It is also known to disrupt 
the REST-CoREST-HDAC complex (78, 82), which is able to inhibit ICP4 expression in 
transient transfection assays (190).  This inhibition is counteracted by the addition of TSA, an 
HDAC inhibitor.  TSA can also partially substitute for ICP0 in the reactivation of gene 
expression from quiescent HSV genomes (246), and the effects of d106 on cellular gene 
expression are similar to those induced by the addition of TSA (97).  In our study it was difficult 
to assess the hyperacetylation of histone H3 on the viral promoters simply by quantifying the 
abundance of AcH3.  The total amount of hyperacetylated histone H3 associated with the viral 
promoters was not uniformly increased in d106 infection over d109 infection (Figure 7).  This 
was most pronounced in HEL cells (Figure 7B).  This is because the amount of total H3 on the 
genome is greatly reduced (Figure 6).  When the amount of AcH3 was normalized to the total 
amount of H3, there was a significant increase in acetylation of the histones associated with 
d106.  Thus, the small number of histones that become associated with the viral genome are 
generally found in an acetylated state.  The histones bound to the d106 HCMV, tk, and gC 
promoters are hyperacetylated in comparison to those on the d109 viral promoters in both HEL 
and Vero cells (Figure 7).  This is consistent with the 1 to 3 order of magnitude increase in gene 
expression from d106 relative to d109.  This hyperacetylation of histone H3 may be due to ICP0-
mediated reduction of HDAC activity.  A number of studies suggest that this is mechanistically 
connected to the disruption of ND10 through the ubiquitin ligase activity of ICP0 and/or the 
ability of ICP0 to disrupt REST-CoREST HDAC complexes (78-81, 83).   
ICP0 expression also resulted in the specific hyperacetylation of histone H3 lysine 9 
(Figure 8).  Although histone acetyltransferase (HAT) activity is somewhat generalized, specific 
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residues of histone tails are generally acetylated by specific HATs.  H3K9 acetylation has been 
linked to the HATs GCN5 and PCAF (75, 125).  ICP0 may be increasing the activity of these 
HATs, as well as others.  ICP0 colocalizes with the HATs CBP and p300, and can be 
coimmunoprecipitated with p300 (166).  Thus, ICP0 may have an effect on HAT activity, 
concurrent with its decrease of HDAC activity, leading to the hyperacetylation of histones bound 
to the viral genome, and a subsequent increase in transcription. 
AcH3 and H3K9Ac were observed on the d106 genome at 4 h p.i. in Vero cells (Figure 
7A, C and 8A, C).  They were not observed on the d106 genome in HEL cells at that time 
(Figure 7B, D and 8B, D).  This may be because positive effects of ICP0 are competing with the 
cellular repression mechanisms, which may be more potent in HEL than in Vero cells.  The 
repression of viral genomes is considered below. 
2.5.3 The formation of repressive chomatin 
H3K9me3 occurs exclusively of H3K9Ac and vice versa.  It is a binding site for HP1γ, which is 
a component of heterochromatin, a repressive chromatin structure. H3K9me3 was seen very 
early in infection of HEL cells (Figure 9B), whereas it was only detected at the 24 h point in 
Vero cells (Figure 9B).  The formation of heterochromatin, as seen by the binding of HP1γ, 
occurs only after the trimethylation of histone H3.  This is consistent with the observation that 
HP1γ binding follows H3K9me3 presence on the d109 genomes in HEL cells (Figure 9B and D).  
HP1γ was detected in Vero cells only on the gC promoter in the d109 genome at 24h p.i.  
Interestingly, gC is the only gene expressed by d109 at a higher level in HEL than in Vero cells 
at 24 h p.i.  This exception aside, the lack of heterochromatin formation in Vero cells is 
consistent with the greater transcriptional activity of the d109 genome in Vero than in HEL cells.  
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This observation also explains the greater ease with which expression can be reactivated with 
HDAC inhibitors, such as TSA, from quiescent genomes in Vero cells as opposed to HEL cells.  
Heterochromatin formation appears to be a process that is inhibited by ICP0.  ICP0 may 
actively prevent the methylation of histones by inhibiting the activity of a histone 
methyltransferase or increasing the activity of a histone demethylase.  However, it is more likely 
that the decreased H3K9me3 and HP1γ binding on the d106 genome is a downstream effect due 
to the decrease in H3 binding and an increase in H3K9 acetylation, with the latter precluding K9 
methylation.  This would not explain the reported decrease in H3K9me following reactivation 
with ICP0, without a decrease in H3 binding (32).  This is remarkable considering that 
methylation of histones is considered a long-lived modification (202), which until recently was 
thought to remain until the histone is replaced or the tail removed (224).  It is possible that the 
reversal of heterochromatin formation upon ICP0-mediated reactivation may be different from 
the mechanism by which it prevents heterochromatin formation. 
The results of these studies indicate that a complex, multistep process occurs in the 
formation of a silenced and heterochromatic state of the HSV genome.  Multiple levels of 
chromatin structure can be observed in the quiescent genome system, and these levels of 
chromatin structure correlate with gene expression levels.  The observations that we made under 
any given condition probably represent the sum of a number of chromatin states.  A 
subpopulation of d109-infected Vero (~10%) and HEL (~0.1%) cells abundantly express GFP 
from HCMV IE promoter (246), indicative of multiple populations of genome states.  
Heterochromatin has been observed in latently infected mouse ganglia (259).  However, it is 
possible that the multiple states of repression observed in this study exist in latency, as well.  
Primary trigeminal neurons are more permissive for gene expression from the d109 genome than 
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support cells (246).  Moreover, quiescent genomes in primary neurons are more readily activated 
by TSA (4, 246).  Reactivation of latently infected ganglia by HDAC inhibitor sodium butyrate 
has also been observed (176).  These observations suggest that genomes persisting in latency are 
not necessarily repressed by heterochromatin.  The more relaxed repression may allow for more 
readily reactivated genomes leading to some viral gene expression, which could lead to abortive 
or productive reactivation events. 
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3.0  REVERSAL OF HETEROCHROMATIC SILENCING OF QUIESCENT HSV-1 
BY ICP0 
3.1 ABSTRACT 
Persisting latent herpes simplex virus genomes are to some degree found in a heterochromatic 
state, and this contributes to reduced gene expression resulting in quiescence.  We used a 
relatively long-term quiescent infection model in human fibroblasts, followed by provision of 
ICP0 in trans, to determine the effects of ICP0 on the viral chromatin state as gene expression is 
reactivated.  Expression of ICP0, even at low levels, results in a reduction of higher order 
chromatin structure and heterochromatin on quiescent viral genomes, and this effect precedes an 
increase in transcription.  Concurrent with transcriptional activation, high levels of ICP0 
expression result in the reduction of the heterochromatin mark trimethylated H3K9, removal of 
histones H3 and H4 from the quiescent genome, and hyperacetylation of the remaining histones.  
In contrast, low levels of ICP0 do not appreciably change histone levels.  These results indicate 
that ICP0 has the ability to alter the chromatin structure of quiescent genomes at multiple levels, 
including higher order chromatin structure, histone modifications, and histone association.  
Additionally, the level of ICP0 expression affected its ability to change chromatin structure, but 
not to reactivate gene expression.  Thus, it is likely that ICP0 exerts its effects through multiple 
mechanisms. 
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3.2 INTRODUCTION 
Herpes Simplex Virus Type 1 (HSV-1) latency is characterized by significantly reduced 
transcription of the viral genome relative to productive infection.  One gene that appears to be 
selectively transcribed is that for the latency associated transcript (LAT) (229, 234).  This 
general repression of gene expression suggests that latent gene expression is controlled by 
epigenetic mechanisms.  Since viral DNA is not extensively methylated (128) expression is 
probably repressed by chromatin structure on the viral genome.  During latency, the viral 
genome is found in an endless, possibly circular, episomal structure, bound by nucleosomes (43, 
110) and heterochromatin (43).   
Periodically in vivo, HSV-1 reactivates, replicates, and can cause recurrent disease.  
Cellular stress (36, 38, 148, 197, 274) and decrease in immune function can both contribute to 
reactivation (67).  Upon reactivation, the full repertoire of viral genes is eventually expressed.  
The exact order of gene expression upon reactivation is unclear, but latently infected explanted 
mouse TG were shown to express genes in a different temporal pattern to that seen in productive 
infection (242), while there is also a decrease in LAT prior to, or concurrent with, lytic gene 
expression (231, 274).  The relative contributions of viral activators of gene expression to 
different aspects of the reactivation process are unclear.  However one activator, the immediate 
early protein ICP0, is required for efficient reactivation from latency in vivo (21-23, 85, 86, 113).   
ICP0 is a promiscuous activator of gene expression at the level of RNA synthesis (51, 72, 
113, 180, 200).  Since it does not directly bind DNA, it has been postulated that ICP0 may exert 
its effects indirectly by interaction with proteins controlling transcription or by influencing some 
general step prior to the assembly of transcription complexes on the vial genome.  ICP0 contains 
an E3 ubiquitin ligase RING finger domain (17, 48), and expression of ICP0 leads to the 
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degradation of a number of proteins, including the centromeric histone variants CENP-A (152), -
B (151), and –C (55), as well as constituents of the PML nuclear bodies (57, 79), which are 
thought to be part of the innate antiviral defense (50, 244).  ICP0 also interacts with, and 
redistributes, class II HDACs (153) and the C-terminus of ICP0 has also been shown to interact 
with and disrupt the repressive histone deacetylase (HDAC)-containing complex of 
HDAC1/HDAC2/REST/CoREST/LSD1 (78, 80, 81, 83), which has been implicated in increased 
viral gene expression.  Additionally, ICP0 may also interact with the histone acetyltransferase 
(HAT) PCAF (139). 
These observations suggest that ICP0 may mediate its transactivation function through 
manipulation of epigenetic control of gene expression by chromatin.  Few studies have 
investigated the changes to viral chromatin upon reactivation of quiescent or latent virus.  A 
study by Coleman, et al. examined ICP0-mediated derepression in a fibroblast model of 
quiescence utilizing replication-deficient HSV mutants (32).  After establishment of quiescence, 
followed by superinfection with an adenovirus providing ICP0, an increase in AcH3 was found 
on the ICP0, ICP4, ICP27, VP16, gC and LAT promoters, and a decrease in the repressive 
modification of histone H3 lysine 9 trimethylation (H3K9me3) was found on the ICP0, ICP27, 
VP16, and gC promoters. These results demonstrated that derepression of quiescent genomes by 
ICP0 induces a global change in chromatin structure, specifically, acetylation of histones 
associated with quiescent viral genomes. 
In the current study, we explored the effects of ICP0 on gene expression and epigenetic 
structure of quiescent HSV genomes using a cell culture model of HSV quiescence in HEL cells. 
The results suggest that there may be multiple mechanisms through which ICP0 exerts its effects, 
and that these mechanisms may depend on the abundance of ICP0.  In addition to its previously 
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demonstrated effects on the acetylation and methylation of histones associated with quiescent 
genomes, ICP0 is able to work at an additional level of chromatin repression, by facilitating the 
removal of preformed nucleosomes from quiescent genomes.  
3.3 MATERIALS AND METHODS 
3.3.1 Cells and viruses 
Experiments were performed using MRC-5 (human embryonic lung) cells obtained from, and 
propagated as recommended by, American Type Culture Collection (ATCC).  The viruses used 
in this study were the HSV-1 IE mutants d105 (96, 211) and d109 (211), as well as the 
adenoviruses Ad.S11D and Ad.S11E4(ICP0) (96).  d105 was propagated on E11 cells and d109 
on F06 cells as previously described (211). 
3.3.2 ChIP 
ChIP was carried out as previously described (66, 213) with a few modifications.  5x106 MRC-5 
cells were plated in 100mm dishes, and were infected by d109 at an MOI of 10 at room 
temperature for 1 hour.  After adsorption, the inoculum was removed and 37°C 5% DMEM was 
added.  Infected cells were maintained at 37°C for 24 hours.  At 24 hpi, the media was replaced 
with fresh media, and infected cells were maintained at 34°C.  On day 4 post infection, media 
was again replaced with fresh media.  At day 7 post infection, d109-infected cells were either 
mock superinfected, superinfected with d105 at an MOI of 10, or superinfected with Ad.S11D 
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and Ad.S11E4(ICP0) at 200 focus forming units (FFU) per cell for 1 hour at room temperature.  
After adsorption, the inoculum was aspirated and the conditioned media (which was saved and 
maintained at 37°C) was replaced.  This was considered time 0 post superinfection.  At the 
indicated times post infection, cells were treated with 1% formaldehyde for 10 minutes at 37°C, 
washed 3 times with cold phosphate-buffered saline (PBS) containing protease inhibitors (67 
ng/ml aprotinin, 1 ng pepstatin, 0.16 mM TLCK [Nα-ptosyl-L-lysine chloromethyl ketone], 1 
mM phenylmethylsulfonyl fluoride [PMSF]), and scraped into PBS containing protease 
inhibitors.  The cells were pelleted at 3,000 rpm for 10 minutes at 4°C and resuspended in cold 
SDS lysis buffer (100 µl per million cells) containing protease inhibitors  (1% SDS, 10mM 
EDTA, 50mM Tris-HCl [pH8.1], 4 µg/ml aprotinin, 2 µg/ml pepstatin, 0.15mM TLCK, and 
0.6mM PMSF), and incubated on ice for 30 minutes.  All other procedures were as described.  
The antibodies used were anti-histone H3 (Abcam, ab1791), anti-histone H4 (Millipore, 05-858), 
anti-acetyl histone H3 (Millipore, 06-599), anti-acetyl histone H4 (Millipore, 06-866), anti-
trimethyl histone H3 lysine 9 (Millipore, 07-422), and anti-heterochromatin protein 1γ 
(Millipore, 05-690).  A “no-antibody control” was included for each ChIP experiment. When 
calculating ChIP results after quantitative PCR (qPCR), the value for the no-antibody control 
was subtracted from the immunoprecipitation results before the percent input of 
immunoprecipitation was calculated. Therefore, any values reported indicate an increase over the 
baseline.  The baseline, or no-antibody control, was always considerably less than the results for 
the specific immunoprecipitations. 
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3.3.3 Micrococcal nuclease digestion 
7.5x106 MRC-5 cells were plated per 100mm dish in 12 dishes.  4 dishes were mock infected, 
and 8 were infected with d109 at an MOI of 20 for 1 hour with rocking every ten minutes at 
room temperature.  After adsorption, the inoculum was removed and 37°C 5% DMEM was 
added.  Infected cells were maintained at 37°C for 24 hours.  At 24 hpi, the media was replaced 
with fresh media, and infected cells were maintained at 34°C.  On day 4 post infection, media 
was again replaced with fresh media.  At day 7 post infection, 4 d109-infected dishes and 4 
mock-infected dishes were superinfected with d105 at an MOI of 10, while the remaining 4 
d109-infected dishes were mock superinfected at room temperature for 1 hour.  After adsorption, 
the inoculum was removed and the conditioned media, which had been saved at 37°C, was 
replaced.  This was considered time 0 post infection.  8 hours post superinfection, nucleoprotein 
complexes were digested by in situ micrococcal nuclease digestion (280) (protocol 1).  Briefly, 
cells were permeabilized with lysolecithin (0.5mg/mL) in permeabilization solution 1 (150mM 
sucrose, 80mM KCl, 35mM HEPES, pH 7.4, 5mM K2HPO4, 5mM MgCl2, 0.5 mM CaCl2) for 
1 minute at 37°C.  Chromatin from each of the three groups of 4 infections was then digested 
with 2.5 mL permeabilization solution 2 (150 mM sucrose, 50 mM Tris-Cl, pH 7.5, 50 mM 
NaCl, 2 mM CaCl2) with 0, 300, 1000, or 3000 gel units micrococcal nuclease (NEB, M0247S) 
for 5 minutes at room temperature.  Cells were scraped into 500µl NDPK buffer (20mM Tris-Cl, 
pH 7.4, 0.2M NaCl, 3mM EDTA, 1% SDS, 0.2 mg/ml proteinase K) and digested at 37°C 
overnight.  DNA was isolated by phenol chloroform extraction and ethanol precipitation, RNase 
A treated, separated on a 2% agarose gel, transferred to a Nytran membrane, probed with 2µg 
32P-labeled nick-translated GFP fragment of pEGFP-C1 digested with AseI and BglII (New 
England Biolabs), and exposed to Hybond film. 
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3.3.4 RNA isolation and reverse transcription 
RNA was isolated with the Ambion RNaqueous -4PCR kit, following the included protocol. 
Briefly, 5x106 MRC-5 cells in 100mm plates were infected at an MOI of 10 by d109 for one 
week and superinfected as in the ChIP experiments.  RNA was harvested at the indicated time 
points by adding 500 μl Lysis/Binding Buffer. Cells were scraped and vortexed. An equal 
volume of 67% ethanol was added, and the solution was added to a filter, which was centrifuged 
at 12,500 RPM at 4°C for 1 minute. The bound RNA was washed with wash buffers 1 and 2/3. 
RNA was eluted with 60 μl 65°C Elution Solution. The RNA was treated with DNase I at 37°C 
for 30 minutes to degrade any residual DNA. 
Reverse transcription was performed using the Ambion reverse transcription kit and 
following the included instructions. 2 μg total RNA was reverse transcribed in a reaction volume 
of 20 μl containing RNase inhibitor, oligo(dT) primers, 1μl MMLV-RT and 2 μl 10x reaction 
buffer. The reaction tube was incubated at 85°C for 3 minutes to remove RNA secondary 
structure, and the reverse transcription reaction was carried out for 1 hour at 44°C. After the 
reverse transcription reaction was complete, the reaction tube was incubated at 95°C for 10 
minutes in order to inactivate the reverse transcriptase. 8 μl of cDNA was diluted 1:8 by adding 
40 μl DNase/RNase free H2O for use in qPCR reactions. Additionally, 1 μg RNA was diluted 
into a total of 60 μl DNase/RNase free H2O for use as a negative control in qPCR reactions. 
3.3.5 qPCR 
Reactions for ChIP or cDNA quantification were performed in triplicate using 2.5 μl of DNA for 
each reaction as described (213), with a few modifications.  Before setting up the 96-well 
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reaction plate, a master mix containing 0.3125 μl of each primer (stock concentration, 1 mM), 
6.25 μl Applied Biosystems SYBR green super mix with 1.0 μM 6-carboxy-X-rhodamine (Bio-
Rad), and 3.125 μl of water for a total of 10 μl for each reaction was made.  The final reaction 
volume was 12.5 μl, including the DNA.  The primers used for ChIP and cDNA quantification 
and their locations relative to the transcription start site of the gene to be analyzed are as 
previously published (66).  d106 DNA was also included in each plate, in a standard curve of 
1:10 dilutions from 250,000 to 25 copies per well, which covers the threshold cycle values for 
the ChIP DNA samples tested.  qPCR was run on a StepOne Plus Real Time PCR machine.  The 
conditions for the run were as follows: stage 1, 95°C for 10 min; and stage 2, 40 cycle repeats of 
95°C for 15 seconds and 60°C for 1 min.  At the end of the run, a dissociation curve was 
completed to determine the purity of the amplified products.  Results were analyzed using the 
StepOne v2.1 software from Applied Biosystems. 
3.4 RESULTS 
3.4.1 RNA expression from quiescent genomes upon reactivation by ICP0 
Immediate early gene expression does not occur during infection with d109.  As a consequence, 
viral gene expression is repressed and the viral genome persists in cells (211).  The virus 
contains a model transgene consisting of the EGFP gene driven by the HCMV IE promoter.  
GFP expression is reduced over time in d109-infected cells, with the greatest level of repression 
in fibroblasts (66, 96, 211, 246).  This repression of GFP expression can be reversed in 
fibroblasts at 7dpi by provision of ICP0 (96, 246).  In order to characterize the effects of 
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epigenetic changes on the quiescent HSV genome induced by ICP0, it was important to measure 
the kinetics of GFP RNA expression upon reactivation.  It was also of interest to examine the 
induction of other viral promoters, to determine whether the effects of ICP0 were specific for the 
HCMV promoter, or are more generally targeted to the HSV-1 genome.   
After quiescent infection was established with d109 for 7 days, MRC-5 cells were 
superinfected with d105 or adenovirus vector, and RNA levels were determined at various time 
points by RT-PCR (Figure 10A).  The steady state level of GFP expression driven by the HCMV 
promoter of d109 was approximately 5x105 copies per µg of total RNA, or approximately an 
average of 10 molecules per cell.  This level of expression was reached by approximately 24 hpi 
(66), and can be found after 7 dpi.  Induction of GFP expression by superinfection with d105 was 
seen by 2 hpi, at which time GFP expression was increased 10-fold.  There was a continuous 
increase in expression over time after 2 hpi, and by 24 hpi with d105, quiescent genomes were 
induced 1000-fold.  
The same pattern of transcriptional induction was seen when ICP0 was provided by an 
adenovirus vector (Figure 10B).  By 24 hpi, GFP expression increased 1000-fold.  Levels of tk 
and gC RNA, which were undetectable in AdS.11D-superinfected cells, increased by greater 
than four orders of magnitude upon infection with AdS.11E4(ICP0).  Additionally, the level of 
transcriptional activation was proportional to the relative strength of each promoter.  These data 
indicate that the effects of ICP0 are general across the entire viral genome, and that 
transcriptional activation depends on the strength of the promoter, once repression is removed by 
ICP0. 
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Figure 10.  Abundance of GFP, tk, or gC mRNA in d109-infected MRC-5 cells after superinfection. 
Infections, RNA isolation, cDNA preparation, and RT-PCR were performed as described in Materials and Methods.  
Quiescent infection by d109 was established for 1 week.  The graphs indicate the number of RNA molecules of GFP 
per μg RNA at the indicated time points after superinfection by d105 (A), or at 24 hpi after the indicated adenovirus 
infection (B). 
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3.4.2 Removal of higher order chromatin structure and repressive epigenetic marks upon 
expression of ICP0 
It has been previously shown that expression of ICP0 prevents the accumulation of 
heterochromatin on the viral genome at representative promoters (29).  Specifically, expression 
of ICP0 prevented accumulation of the heterochromatin mark H3K9me3, as well as deposition of 
HP1γ at the tk, gC, and HCMV promoters, and that these effects were correlated with 
transcriptional activation (66).  We wished to test whether ICP0 could also remove 
heterochromatin marks from repressed, quiescent genomes, once a highly repressed state was 
established.  ChIP assays were performed following d105- and AdS.11E4(ICP0)-superinfection 
reactivation. 
ChIP assays for HP1γ and H3K9me3 on the HCMV promoter were performed on d109 
infected cells that were superinfected for different lengths of time with d105 (Figure 11A and B).  
Expression of ICP0 from d105 caused the removal of HP1γ beginning at 1 hour post-
superinfection (Figure 11A), which preceded a detectable increase in GFP RNA (Figure 10).  
HP1γ levels continued to decrease over time, and by 24 hours post infection, were approximately 
one-fifth the level of mock-superinfected cells.  H3K9me3 levels did not decrease until 2 hours 
post-superinfection with d105 (Figure 11B).  This is presumably because access to histone 
modifications is limited when they are found in higher-order heterochromatin structures, and 
binding proteins such as HP1γ must first be removed.  H3K9me3 was reduced by 2 hours post-
superinfection, and also continued to decrease over time.  The ICP0-mediated reduction in 
heterochromatin on the d109 HCMV promoter was concurrent with reactivation of gene 
expression. 
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In order to investigate whether the removal of heterochromatin was a general effect, or 
limited to the HCMV promoter, we tested the effects of superinfection with adenovirus-provided 
ICP0 on the quiescent d109 genome.  After d109 quiescence was established for 7 days, cells 
were superinfected with either AdS.11D or AdS.11E4(ICP0).  24 hpi, ChIP was performed, and 
the levels of heterochromatin marks on the tk and gC promoters were determined.  Additionally, 
the EGFP coding sequence was assayed.  This was necessary, because AdS.11D and 
AdS.11E4(ICP0) contain the secretory alkaline phosphatase reporter gene under control of the 
HCMV promoter (96).   
Expression of ICP0 from the adenovirus vector caused a reduction in HP1γ on all three 
classes of viral promoter, with the greatest decrease on the tk promoter (Figure 11C).  
Additionally, H3K9me3 was reduced on all three promoters (Figure 11D).  These results 
demonstrate that ICP0 expression results in a decrease in heterochromatin on quiescent genomes, 
that this reduction is not dependent on the viral context in which ICP0 is provided, and that the 
reduction of heterochromatin is general across the quiescent viral genome. 
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Figure 11.  Repressive chromatin modifications associated with the tk, gC and HCMV promoters, and GFP 5’ 
region of d109 in MRC-5 cells after superinfection. 
 
Chromatin Immunoprecipitation (ChIP) with antibodies to HP1γ (A and C) and H3K9me3 (B and D), and followed 
by RT-PCR with primer pairs corresponding to the indicated promoter regions were performed as described in the 
Materials and Methods.  Graphs show the percentages of total genomes bound after superinfection with d105 at the 
indicated time points (A and B), or after superinfection with the indicated adenovirus at 24 hpi (C and D).  Error 
bars represent standard error of the mean from multiple experiments. 
 
3.4.3 Removal of histones upon expression of ICP0 
The basic unit of chromatin structure is the nucleosome, which is an octamer of 4 histone 
proteins, H2A, H2B, H3 and H4, around which approximately 150 base pairs of DNA are 
wrapped (154).  Nucleosomes are associated with quiescent HSV DNA (110), while 
transcriptionally active HSV DNA is most likely not bound by stable classical nucleosomes (117, 
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130, 136).  Previously, it was demonstrated that expression of ICP0 during productive infection 
prevents the accumulation of histone H3 on the viral genome (29), and that this effect is also 
seen during the establishment of quiescence (66).  In order to determine whether histones are 
removed during ICP0-mediated reactivation, ChIP was performed for histones H3 and H4 upon 
ICP0-mediated reactivation of quiescent d109. 
As in previous experiments, quiescence of d109 was established for one week in MRC-5 
cells, and cells were superinfected with d105 for 1, 2, 4, or 24 hours (Figure 12).  Histone H3 and 
H4 occupancy of the d109 HCMV promoter was reduced upon expression of ICP0 (Figure 12).  
This reduction in histone occupancy is coincident with RNA expression (Figure 10).   
In order to extend these results and further probe the nucleosomal structure of quiescent 
genomes, and the changes induced upon ICP0 expression, in situ micrococcal nuclease digestion 
was performed.  Quiescent infection with d109 was established for one week, and cells were 
either superinfected with d105, or mock superinfected.  8 hours post superinfection, the cells 
were permeabilized, and increasing concentrations of micrococcal nuclease were added.  Total 
cell-associated DNA was isolated, size-fractionated on an agarose gel, and stained with ethidium 
bromide to visualize bulk cellular DNA.  The DNA was transferred onto a nylon membrane, and 
probed with a 32P-labelled GFP DNA probe.  Therefore, the observed MN patterns represent the 
chromatin structure of the gene unique to the quiescent genomes.  The ethidium bromide stained 
gel showed the standard nucleosomal pattern of the bulk cellular DNA (Figure 13).  The 
hybridization signals revealed that the quiescent d109 genomes were more resistant to MN 
digestion than bulk cellular DNA (Figure 13), implying that these genomes are packaged in a 
higher order structure.  If quiescent genomes are packaged in regular nucleosomes, additional 
structure masks this by preventing access by micrococcal nuclease.  Provision of ICP0 by d105 
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resulted in a chromatin configuration that was degraded by low concentrations of micrococcal 
nuclease.  The GFP gene of ICP0-reactivated d109 is at least as sensitive to MN digestion as 
bulk cellular DNA.  These results are consistent with the ChIP data demonstrating removal of 
both heterochromatin and histones from quiescent d109 upon ICP0 expression. 
 
 
Figure 12.  Binding of histones H3 and H4 to the HCMV promoter of d109 in MRC-5 cells after 
superinfection with d105. 
 
ChIP with antibodies to histones H3 and H4, and RT-PCR were performed as described in the legend to Figure 11 to 
determine the percentages of genomes bound by histones H3 (A) and H4 (B).  Graphs show the percent of total 
genomes bound at the indicated times post infection with d105.  Error bars represent standard error of the mean from 
multiple experiments. 
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Figure 13.  Micrococcal nuclease digestion of d109-infected MRC-5 cells after superinfection. 
MRC-5 cells were mock- or d109-infected for one week, followed by superinfection with the indicated virus.  Cells 
were permeabilized and digested for 5 minutes with 0, 200, 1000, or 300 units micrococcal nuclease.  The DNA was 
isolated from the nuclei at 8 h post infection, purified, and fractionated on 2.0% agarose gels.  The agarose gels were 
stained with ethidium bromide (left) and transferred to NYTRAN membranes for Southern Blot hybridization as 
described in the Material and Methods section.  The Southern Blots (right) were probed with 32P-labeled GFP DNA, 
washed and exposed to X-ray film.  Shown are the autoradiographic images of the probed blots (right). 
 
 
 
In a study by Coleman, et al., ICP0 provided by a superinfecting adenovirus failed to 
cause the removal of histones from quiescent HSV genomes during reactivation, which contrasts 
with the effects seen when ICP0 was expressed by d105.  We therefore tested whether ICP0 
expressed from AdS.11E4(ICP0) caused the reduction of histone occupancy on the quiescent 
d109 genome.  Using ChIP analysis, it was seen that ICP0 expression from AdS.11E4(ICP0) did 
not cause appreciable reduction of histone H3 on either the tk or gC promoter, or EGFP gene, 
when compared to the empty adenoviral vector (Figure 14).  Histone H4 occupancy was reduced 
a minimal amount on all three regions tested (Figure 14).  Despite the lack of histone removal 
from quiescent genomes during AdS.11E4(ICP0) superinfection (Figure 14), GFP expression 
was activated to the same extent as in d105 superinfection (Figure 10).  This implies that the 
removal of histones from quiescent genomes is not required for significant ICP0-mediated 
reactivation. 
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Figure 14.  Binding of histones H3 and H4 to the tk and gC promoters and GFP 5’ region of d109 in MRC-5 
cells after superinfection with adenovirus. 
 
ChIP with antibodies to histones H3 and H4, and RT-PCR were performed as described in the legend to Figure 11 to 
determine the percentages of d109 genomes bound by histones H3 (A) and H4 (B).  Graphs show the percent of total 
genomes bound at 24 hpi with the indicated adenovirus.  Error bars represent standard error of the mean from 
multiple experiments. 
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3.4.4 Hyperacetylation of histones is a result of ICP0 expression 
It has been shown in a number of studies that infection with HSV results in global 
hyperacetylation of histones (117), and that ICP0 expression causes hyperacetylation of histones 
bound to the HSV genome (29, 32, 66).  ICP0 has also been shown to cause the disruption of the 
repressive complex HDAC1/HDAC2/REST/CoREST/LSD1 (78, 80, 81, 83).  The effects of 
ICP0 expression also seem to share some similarities to HDAC inhibitors such as trichostatin A 
(97).   
In order to determine the effects of ICP0 on histone acetylation during activation of 
quiescent HSV, we performed ChIP on a time course following d105 superinfection and 
compared it with expression data at the same time points.  In order to account for the reduction 
of histones on the quiescent genome upon reactivation, AcH3 and AcH4 levels were normalized 
to the bulk amount of histones H3 and H4 (Figure 12).  As has been seen previously, ICP0 
expression by d105 caused hyperacetylation of the histones that were bound to d109 HCMV 
promoter (Figure 15).  However, the activation of transcription under these conditions (Figure 
10A) preceded the appearance of acetylated histones.  This may indicate that hyperacetylation of 
the histones bound to the reactivating quiescent genome is not an event required for the initiation 
of transcriptional reactivation.  This hyperacetylation could be significant in that it may act to 
prevent reestablishment of repression and allow for continuous access to the genome by the 
transcriptional apparatus. 
ChIP experiments performed after adenovirus superinfection demonstrated that 
expression of ICP0 from AdS.11E4(ICP0) caused an increase in acetylation of histone H3 and 
H4 on all three genes tested (Figure 16).  The percent of H3 acetylated on viral promoters is most 
significantly increased on the gC promoter, while it is only slightly increased on the GFP gene 
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and tk promoter, whereas the fraction of hyperacetylated H4 is increased to a small extent on the 
tk and gC promoters, and is greatly increase on the HCMV promoter.  These results indicate that 
expression of ICP0 causes hyperacetylation of histones across the viral genome, which has also 
been seen previously (32).  Hyperacetylation of viral-bound histones is seen both when histones 
are removed from the viral genome, and when they remain, showing that these effects are not 
necessarily tied together by the same mechanism.  Therefore, the effects of ICP0 on the 
acetylation and higher order chromatin structure of quiescent HSV genomes may be mediated 
through different mechanisms. 
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 Figure 15.  Binding of hyperacetylated histone H3 and hyperacetylated H4 to the HCMV promoter of d109 in 
MRC-5 cells after superinfection with d105. 
 
ChIP with an antibody to AcH3 and AcH4 and RT-PCR were performed as described in Figure 11 to determine the 
percentage of d109 genomes bound by AcH3 or AcH4 at the indicated times post infection with d105.  In order to 
compensate for the changing amounts of total histone H3 and H4, AcH3 was normalized to the amount of histone 
H3 (A) and AcH4 was normalized to the amount of histone H4 (B) on the genome by dividing the percent of 
acetylated histone by the percent of total histone (Fig. 3).  Error bars represent standard deviations from multiple 
experiments. 
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Figure 16.  Binding of hyperacetylated histone H3 and hyperacetylated H4 to the tk and gC promoters and 
GFP 5’ region of d109 in MRC-5 cells after superinfection with adenovirus. 
 
ChIP with an antibody to AcH3 and AcH4 and RT-PCR were performed as described in Figure 11 to determine the 
percentage of d109 genomes bound by AcH3 or AcH4 at the indicated times post infection with d105.  In order to 
compensate for the changing amounts of total histone H3 and H4, AcH3 was normalized to the amount of histone 
H3 (A) and AcH4 was normalized to the amount of histone H4 (B) on the indicated regions of the genome by 
dividing the percent of acetylated histone by the percent of total histone (Fig. 3).  Error bars represent standard 
deviations from multiple experiments. 
 
 83 
3.5 DISCUSSION 
ICP0 is a promiscuous transactivator of gene expression, and is one of several viral proteins that 
can reactivate gene expression from quiescent genomes.  Some of the effects of ICP0 are similar 
to those of the HDAC inhibitor trichostatin A (97, 246), but as quiescence is established, 
inhibiting histone deacetylases is not sufficient to activate gene expression (246). However, ICP0 
maintains the ability to reactivate the quiescent virus (246).  Additionally, replicating HSV 
lacking ICP0 cannot participate in recombination with quiescent HSV-1 (168, 246), implying 
that quiescent genomes are inaccessible to viral proteins and the recombination machinery in the 
absence of ICP0.  Therefore, it appears that ICP0 is involved in the removal of a repressive 
mechanism, and this mechanism involves perturbation of a higher order chromatin structure.  In 
this study, quiescence was established with the HSV mutant d109, which expresses no IE 
proteins and cannot replicate in noncomplementing cells.  After one week, d109 was reactivated 
by providing ICP0 in trans, either by the HSV-1 mutant d105, or by an adenovirus vector.  RNA 
expression was quantified, and ChIP was used to determine the relationship of chromatin 
structure to gene expression patters upon reactivation of viral gene expression.  We determined 
the presence of heterochromatin on the quiescent genomes, whether histones were removed, and 
whether remaining histones were acetylated, and correlated the chromatin structure temporally 
with gene expression, both from the HCMV IE promoter, and from representative E and L genes.   
3.5.1 Gene expression upon ICP0 induced reactivation 
The steady state level of GFP expression from quiescent d109 in MRC-5 cells was 
approximately 10 mRNA copies per cell.  The majority of this expression likely occurs in the 
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few (less than 0.1%) of cells which do not become repressed (246).  Upon provision of ICP0 by 
d105 superinfection, expression of GFP mRNA increased, 10-fold by 2 hours, 150-fold by 4 
hours, and approximately 1000-fold by 24 hours post superinfection (Figure 10).   
Due to the absence of ICP4, ICP0 is over expressed in the d105 background.  In contrast, 
the amount of ICP0 expressed in AdS.11E4(ICP0) infected cells at 24 h post infection is less 
than 1000 times that expressed in d105 infected cells, and approximately equal to that seen in the 
first hour of infection by wt virus (96).  Therefore, we also measured the ability of ICP0 
expressed from AdS.11E4(ICP0) to reactivate gene expression.  As seen in Figure 10, the level 
of mRNA GFP accumulating at 24 hpi was equivalent in d105 and AdS.11E4(ICP0) 
superinfection.  As we have previously shown (96), this result reinforces the finding that even 
small amounts of ICP0 can alleviate repression to an extent that allows for full transcriptional 
activation.  Additionally, superinfection with AdS.11E4(ICP0) allowed the measurement of 
detectable levels of the E and L representative genes, tk and gC.  The level of activation of these 
genes varied with their relative promoter strength, as previously reported (66). 
3.5.2 Removal of heterochromatin as a function of ICP0 
It has been shown that ICP0 prevents the association of HP1γ with incoming viral genomes as 
quiescence is established (66).  In this study, it was determined that ICP0 expression in trans can 
cause the removal of HP1γ from highly heterochromatic quiescent genomes.  This effect was 
seen both in d105 and AdS.11E4(ICP0) superinfection, indicating that even small amounts of 
ICP0 can facilitate the removal of HP1γ.  Additionally, during AdS.11E4(ICP0) superinfection, 
all three promoter classes tested showed a reduction in HP1γ, indicating that this is a general 
effect across the genome. The removal of HP1γ occurred by 1 hpi, which precedes a measurable 
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increase of RNA levels.  This is presumably because higher order chromatin structure must be 
removed before the transcriptional machinery can access the DNA. 
A previous report (32) determined that HP1α was enriched at viral promoters after 
superinfection with HSV-2, while no large change in HP1α levels was observed after ICP0 
expression by an adenovirus.  The differences between these observations and our results can be 
explained by several possibilities.  First and most obvious, is that although the three isoforms of 
HP1 share homology and similar roles in gene silencing, they have different localization 
characteristics and may have different interaction partners (149, 157).   Thus HP1α localizes 
exclusively to heterochromatin, while HP1γ has been shown to localize to both heterochromatin 
and silenced euchromatic regions.  This suggests that the HP1 isoforms play different roles in 
HSV-1 silencing during quiescence.  Additionally, the previous study employed phosphonoacetic 
acid to prevent replication in HSV-2 superinfection, and doxycycline to drive expression during 
adenovirus superinfection.  These chemicals may have altered the chromatin dynamics on 
quiescent virus, as we have seen that even replacing conditioned media with fresh media can 
drastically change histone occupancy levels on quiescent viral genomes (data not shown).   
Trimethylation of histone H3 lysine 9 is associated with repression of transcription (8), 
and recruits HP1 (5).  After superinfection with d105, a reduction of H3K9me3 on the HCMV 
promoter was seen by 2 hpi, concurrent with a detectable rise in GFP RNA levels.  As would be 
expected, the change in H3K9me3 levels followed a reduction in HP1γ association with the 
quiescent genome.  The reduction of H3K9me3 was also found on gC and tk promoters after 
AdS.11E4(ICP0) superinfection, showing that the reduction of heterochromatin is a general 
effect across the quiescent genome.  The temporal order of heterochromatin removal suggests 
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that HP1γ removal is required before changes to histone modifications can occur, and before 
transcriptional activation can be induced.   
3.5.3 The abundance of ICP0 may affect the removal and acetylation of histones from 
quiescent genomes 
Previously, it has been seen that superinfection with an adenovirus expressing ICP0 does not 
result in the removal of histone H3 from quiescent HSV-1 (32), while the presence of ICP0 
prevents the accumulation of histone H3 and quiescence (66).  These results taken together 
suggest that ICP0 expression can prevent histone deposition on incoming viral genomes, but that 
it cannot cause the removal of histones from previously chromatinized quiescent genomes.  
Further analysis, however, reveals a more complex picture of ICP0 function. 
When ICP0 was overexpressed in trans from d105, histones H3 and H4 were removed 
from the HCMV promoter of the quiescent d109 genome, concurrent with gene expression, as 
well as with the decrease of H3K9me3.  Micrococcal nuclease analysis of the GFP gene revealed 
that d105 infection resulted in greater susceptibility to micrococcal nuclease then even cellular 
DNA, and no detectable banding pattern, indicating that both higher order chromatin structure, as 
well as nucleosomes were removed from the d109 GFP gene upon ICP0 expression.  However, 
when ICP0 is expressed at low levels, which more closely mimics wild-type levels, from 
AdS.11E4(ICP0), histone H3 was not removed from the HCMV, tk, or gC promoters of d109, 
while there was a slight reduction in histone H4 occupancy at these promoters.   
While the removal of histones may vary with the amount of ICP0 expressed, 
transcriptional activity remains approximately equal after ICP0-induced reactivation.  This 
indicates that full histone removal is not essential for transcription from quiescent genomes to 
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occur.  Additionally, it has been shown previously that expression of small amounts of ICP0 
from AdS.11E4(ICP0) can activate gene expression from quiescent d109 without perturbing 
cellular gene expression, whereas expression of large amounts of ICP0 from d106 (from which 
d105 was derived) results in significant changes to the cellular expression pattern (96). 
A possible explanation for this phenomenon lies in the multifunctional nature of ICP0, 
which has at least two distinct regions that are required for its full transcriptional activation 
function.  The RING finger region is an E3 ubiquitin ligase, and is responsible for the 
degradation of multiple proteins, many of which are involved in the cellular antiviral response, as 
well as heterochromatin maintenance (25, 55, 151, 152) and the DNA damage response (133, 
143, 188).  When the RING finger is disrupted, this activity is lost.  Thus, the enzymatic activity 
of the RING finger is essential for ICP0 function.  However, a number of studies (21-23, 282), 
have shown that regions of the C-terminus of ICP0 are required for full activation of gene 
expression.  When the C-terminus is truncated, the RING finger portion of ICP0 has a reduced 
ability to activate gene expression.   
This phenotype may be explained, in part, by recent work demonstrating a region of the 
C-terminus of ICP0 responsible for disrupting the repressive complex formed by 
HDAC1/HDAC2/REST/CoREST/LSD1 (78, 80, 81, 83, 205).  A region of ICP0 with homology 
to CoREST has the ability to physically disrupt and cause the translocation of the CoREST 
repressive complex.  The ability of ICP0 to disrupt this complex may require relatively large 
amounts of ICP0 compared to its enzymatic function, and may explain the differences seen in 
removal of histones from quiescent genomes. 
Abundant expression of ICP0 was also required for full hyperacetylation of histones H3 
and H4.  Upon d105 superinfection, the histones H3 and H4 remaining on the quiescent genome 
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were hyperacetylated.  When ICP0 was provided by superinfection with AdS.11E4(ICP0), 
however, only the gC promoter shows a large increase in the hyperacetylation of remaining 
histone H3.  Hyperacetylation of histone H4 was only prominent on the GFP gene after 
AdS.11E4(ICP0) superinfection.  Taken together with the lack of significant histone removal 
when ICP0 is expressed at low levels, this lack of full hyperacetylation of histones supports the 
hypothesis that the physical disruption of the CoREST complex may require more abundant 
levels of ICP0, while the enzymatic functions of ICP0 occur even at low expression levels.   
The results of these studies indicate that ICP0 expression is able to cause the disruption 
heterochromatin on quiescent HSV-1 genomes.  The loss of HP1γ and a higher order chromatin 
structure precedes reactivation of gene expression, while the decrease in the heterochromatin 
mark H3K9me3 occurs concurrently with detectable transcriptional activation.  Additionally, 
large amounts of ICP0 were able to facilitate the removal of histones from quiescent virus, while 
small amounts were not, suggesting that ICP0 may exert its function through multiple 
mechanisms.  It also demonstrates that full transcriptional activation does not require full histone 
removal.  Lastly, hyperacetylation of histones temporally followed derepression of gene 
expression, suggesting that this is either a bystander effect of the other functions of ICP0, or 
acetylation of histones is a means by which the virus maintains a euchromatic state during 
reactivation. 
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4.0  FUNCTIONAL DOMAINS OF ICP0 INVOLVED IN REVERSAL OF 
EPIGENETIC SILENCING OF QUIESCENT HSV-1 
4.1 ABSTRACT 
ICP0 is a multifunctional transcriptional activating protein required for the efficient reactivation 
of latent HSV-1.  Multiple regions of ICP0 play a role in its activity, the most prominent of 
which appears to be a RING finger motif, an E3 ubiquitin ligase domain responsible for the 
degradation of numerous proteins.  Additional regions of ICP0 have been implicated in other 
functions, including the disruption of a cellular repressor complex with histone deacetylase and 
methylase activity (REST/CoREST/HDAC1/2/LSD1).  We used quiescent infection of MRC-5 
cells, followed by superinfection with various viral mutants of ICP0 to quantify the contributions 
of the RING finger (RF) and other activities to alter the chromatin structure and reactivate gene 
expression from quiescent d109.  Superinfection of quiescently infected MRC5 cells with wild-
type virus resulted in a 1000-fold increase in transcription from the HCMV promoter of d109, 
the removal of heterochromatin and histones, and an increase in histone marks associated with 
activated transcription (acetylation of histones and methylation of H3K4).  An RF mutant was 
unable to reactivate transcription or remove heterochromatin from d109, while a mutant 
previously shown to be unable to interact with CoREST (R8507) was able to reactivate gene 
expression 100-fold from quiescent d109, and partially remove heterochromatin.  However, 
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R8507 expression did not result in the acetylation of histones H3 and H4 or the methylation of 
histone H3K4.  Additionally, the RF mutant and R8507 were unable to functionally complement 
one another, demonstrating that both regions must be on the same molecule for full ICP0 
function.  These results indicate that the RF is necessary and sufficient to reactivate transcription, 
but other activities, possibly the disruption of the CoREST repressor complex, is required for full 
reactivation of gene expression.  This implies that ICP0 derepresses quiescent genomes and 
reactivates gene expression through interference with multiple cellular repression mechanisms. 
4.2 INTRODUCTION 
Lytic replication of herpes simplex type 1 (HSV-1) occurs in the epithelial cells, followed by 
viral infection of the sensory neurons enervating the site of initial infection.  The viral capsid 
travels via retrograde transport to the nucleus, where the DNA becomes latent.  Latency is 
characterized by circularization of the genome and an almost complete lack of gene express, with 
the exception of the latency associated transcript.  This global shutdown of transcription 
suggested that an epigenetic mechanism was involved in the silencing of HSV-1 during latency. 
Since HSV-1 DNA is not extensively methylated (128), it is likely that chromatin 
structure helps to control transcriptional repression.  Chromatin can epigenetically modulate gene 
expression on a number of levels.  Histones can physically impede access of the transcriptional 
machinery to the DNA.  Certain modifications of the histone tails can recruit repressive or a 
transcriptionally activating proteins to promoters.  For example, the repressive chromatin mark 
trimethylation of histone H3 lysine 9 (H3K9me3) has been shown to form a binding site for, and 
recruit, heterochromatin protein 1 γ (HP1γ). 
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Latent viral DNA was shown to be in a chromatin structure in mice (43) and in cell 
culture (110), and it has been previously seen in a cell culture model of quiescence that incoming 
viral DNA is chromatinized in the absence of viral immediate early (IE) genes (66).  
Specifically, it was seen that, in HEL cells, by four hours post infection (hpi), histones are 
deposited on the incoming genome, and these histones begin to acquire trimethylation of histone 
H3K9.  By 24 hpi, HP1γ becomes associated with viral promoters.  This accumulation of 
heterochromatin is coincident with a decrease in gene expression, and helps to explain the global 
lack of gene expression during viral latency and quiescence. 
Periodically, latent viral DNA can reactivate and cause recurrent disease at the initial site 
of infection.  Reactivation stimuli include various forms of cellular stress (36, 38, 148, 197, 274) 
and diminished immune function (67). The immediate early protein ICP0 is required for efficient 
reactivation from latency in vivo (21-23, 85, 86, 113).  ICP0 is a promiscuous transactivator of 
gene expression.  ICP0 does not bind DNA, but mediates its functions through interactions with 
a large number of cellular proteins, including those involved in cell cycle regulation (44, 257), 
transcription (44, 115), the double-stranded break repair mechanism (108, 188), and the 
interferon response (41, 169) 
Many of ICP0’s functions are the result of degradation of cellular proteins through its 
RING finger domain (17, 48).  The RING finger is a C3HC4 zinc binding region that coordinates 
two zinc ions and functions as an E3 ubiquitin ligase (7, 48, 52, 61).  One of the major 
degradation targets of the RING finger domain are constituents of the ND10, or PML, bodies 
(25, 57).  Incoming viral genomes localize next to ND10 bodies, which are upregulated by 
interferon (54, 245), and are thought to play a role in the intrinsic cellular antiviral response (50).  
ICP0 colocalizes with, and causes the degradation of, the major ND10 components promyelytic 
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leukemia (PML) and Sp100 proteins (79).  The RING finger is also responsible for the 
degradation of the centromeric proteins CENP-A (152), CENP-B (151), and CENP-C (55).  
RING finger mutations that disrupt zinc binding eliminate the ability of ICP0 to degrade 
components of ND10 bodies, as well as other proteins, and eliminate the transcriptional 
activation function of ICP0. 
ICP0 has also been shown to interact with histone deacetylases in a RING finger-
independent manner.  ICP0 interacts with, and causes the relocalization of, class II HDACs 
(153), and consequently inhibits their HDAC activity.  The C-terminal amino acids 537-613 of 
ICP0 have homology to CoREST, and amino acids 669-718 are involved in binding to CoREST.  
This allows ICP0 to interact with and disrupt the REST/CoREST/HDAC1/2/ LSD1 repressor 
complex (78, 80, 81, 83), leading to the relocalization of components of the complex.  When this 
region of ICP0 is mutated to abrogate CoREST binding, viral replication and degradation of 
PML is delayed, but not completely eliminated (83).  Truncation mutants of ICP0 show similarly 
intermediate phenotypes, with truncation before or in the CoREST homology region showing 
partial loss of activation function and a loss of full ability to reactivate in explanted mouse 
ganglia (21). 
Previously, we have shown that ICP0 expression is able to prevent the accumulation of 
histones, repressive histone modifications, and higher-order chromatin structure on the incoming 
viral genome, as well as cause the hyperacetylation of the few histones that do bind (66).  In the 
current study, we have examined the ability of mutants in the RING finger and CoREST regions 
of ICP0 to reactivate gene expression from quiescent HSV-1.  The chromatin structure of highly 
repressed, quiescent genomes before and after ICP0-mediated reactivation was characterized, 
and agrees with the previously published observations of ICP0 mutants.  It was found that 
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disruption of the RING finger prevents ICP0’s ability to remove heterochromatin from quiescent 
genomes, or to activate gene expression from genomes which have undergone various levels of 
repression.  Disruption of CoREST binding resulted in a phenotype that was intermediate 
between ICP0-null viruses and wild-type ICP0.  Thus partial transcriptional activation occurred, 
and heterochromatin was partially removed from the quiescent viral genomes upon provision of 
mutant ICP0 in trans.  These results indicate that while the RING finger is absolutely necessary 
for ICP0 to cause the removal of heterochromatin and reactivation of transcription from 
epigenetically repressed quiescent genomes, the C-terminus is necessary for ICP0’s full activity. 
4.3 MATERIALS AND METHODS 
4.3.1 Cells and viruses 
Experiments were performed using MRC-5 (human embryonic lung) cells, Vero (African Green 
Monkey Kidney) cells, and U2OS (human osteosarcoma) cells, obtained from, and propagated as 
recommended by, American Type Culture Collection (ATCC).  F11 cells were maintained as 
previously described (211).  The viruses used in this study were the IE mutant d109 (211), wild-
type HSV-1 (KOS), the ICP0-negative mutant n212 (23), the ICP0 RING finger point mutant 
(referred to as RF) (146), and the CoREST binding mutant R8507 (83) and control mutant R8508 
(83).  The RF virus (originally created by Saul Silverstein), the R8507, and R8508 viruses were a 
kind gift of Bernard Roizman.  d109 was propagated on F06 cells as described (211), and all 
other viruses were propagated on U2OS cells to minimize differences between the viral stocks. 
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4.3.2 ChIP 
ChIP was carried out as previously described (66, 213) with a few modifications.  5x106 MRC-5 
cells were seeded in 100mm dishes, and were infected by d109 at an MOI of 10 at room 
temperature for 1 hour.  After adsorption, the innoculum was removed and 37°C 5% DMEM was 
added.  Infected cells were maintained at 37°C for 24 hours.  At 24 hpi, the media was replaced 
with fresh media, and infected cells were maintained at 34°C.  On day 4 post infection, media 
was again replaced with fresh media.  At day 7 post infection, d109-infected cells were either 
mock superinfected, or superinfected with various mutants at an MOI of 10 PFU per cell for 1 
hour at room temperature.  After adsorption, the innoculum was aspirated and the conditioned 
media (which was saved and maintained at 37°C) was replaced.  This was considered time 0 post 
superinfection.  At 4 hpi, cells were treated with 1% formaldehyde for 10 minutes at 37°C, 
washed 3 times with cold phosphate-buffered saline (PBS) containing protease inhibitors (67 
ng/ml aprotinin, 1 ng pepstatin, 0.16 mM TLCK [Nα-ptosyl-L-lysine chloromethyl ketone], 1 
mM phenylmethylsulfonyl fluoride [PMSF]), and scraped into PBS containing protease 
inhibitors.  The cells were pelleted at 3,000 rpm for 10 minutes at 4°C and resuspended in cold 
SDS lysis buffer (100 µl per million cells) containing protease inhibitors  (1% SDS, 10mM 
EDTA, 50mM Tris-HCl [pH8.1], 4 µg/ml aprotinin, 2 µg/ml pepstatin, 0.15mM TLCK, and 
0.6mM PMSF), and incubated on ice for 30 minutes.  All other procedures were as described.  
The antibodies used were anti-histone H3 (Abcam, ab1791), anti-histone H4 (Millipore, 05-858), 
anti-acetyl histone H3 (Millipore, 06-599), anti-acetyl histone H4 (Millipore, 06-866), anti-
trimethyl histone H3 lysine 9 (Millipore, 07-422), anti-dimethyl histon H3 lysine 4 (Millipore, 
07-030) and anti-heterochromatin protein 1γ (Millipore, 05-690).  A “no-antibody control” was 
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included for each ChIP experiment and the value for the no-antibody control was subtracted from 
the immunoprecipitation results before the percent input of immunoprecipitation was calculated.  
4.3.3 RNA isolation and reverse transcription 
RNA was isolated with the Ambion RNaqueous -4PCR kit, following the included protocol. 
Briefly, 5x106 MRC-5 cells in 100mm plates were infected at an MOI of 10 by d109 for one 
week and superinfected as in the ChIP experiments.  RNA was harvested at the indicated time 
points by adding 500 μl Lysis/Binding Buffer. Cells were scraped and vortexed. An equal 
volume of 67% ethanol was added, and the solution was added to a filter, which was centrifuged 
at 12,500 RPM at 4°C for 1 minute. The bound RNA was washed with wash buffers 1 and 2/3. 
RNA was eluted with 60 μl 65°C Elution Solution. The RNA was treated with DNase I at 37°C 
for 30 minutes to degrade any residual DNA. 
Reverse transcription was performed using the Ambion reverse transcription kit and 
following the included instructions. 2 μg total RNA was reverse transcribed in a reaction volume 
of 20 μl containing RNase inhibitor, oligo(dT) primers, 1μl MMLV-RT and 2 μl 10x reaction 
buffer. The reaction tube was incubated at 85°C for 3 minutes to remove RNA secondary 
structure, and the reverse transcription reaction was carried out for 1 hour at 44°C. After the 
reverse transcription reaction was complete, the reaction tube was incubated at 95°C for 10 
minutes in order to inactivate the reverse transcriptase. 8 μl of cDNA was diluted 1:8 by adding 
40 μl DNase/RNase free H2O for use in qPCR reactions. Additionally, 1 μg RNA was diluted 
into a total of 60 μl DNase/RNase free H2O for use as a negative control in qPCR reactions. 
 96 
4.3.4 qPCR 
Reactions for ChIP or cDNA quantification were performed in triplicate using 2.5 μl of DNA for 
each reaction as described (213), with a few modifications.  Before setting up the 96-well 
reaction plate, a master mix containing 0.3125 μl of each primer (stock concentration, 1 mM), 
6.25 μl Applied Biosystems SYBR green super mix with 1.0 μM 6-carboxy-X-rhodamine (Bio-
Rad), and 3.125 μl of water for a total of 10 μl for each reaction was made.  The final reaction 
volume was 12.5 μl, including the DNA.  The primers used for ChIP and cDNA quantification 
and their locations relative to the transcription start site of the gene to be analyzed are as 
previously published (66).  d106 DNA was also included in each plate, in a standard curve of 
1:10 dilutions from 250,000 to 25 copies per well, which covers the threshold cycle values for 
the ChIP DNA samples tested.  qPCR was run on a StepOne Plus Real Time PCR machine.  The 
conditions for the run were as follows: stage 1, 95°C for 10 min; and stage 2, 40 cycle repeats of 
95°C for 15 seconds and 60°C for 1 min.  At the end of the run, a dissociation curve was 
completed to determine the purity of the amplified products.  Results were analyzed using the 
StepOne  v2.1 software from Applied Biosystems. 
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4.4 RESULTS 
4.4.1 Plaque-forming ability of ICP0 mutants 
HSV-1 that does not express ICP0 displays a deficiency in plaque formation in non-
complementing cells.  The requirement for ICP0 is dispensed with in U2OS cells (278), which 
are likely to be missing a pathway or protein required for repression of incoming HSV-1 
genomes (89).  Additionally, L7 cells, which are Vero cells stably transfected with ICP0 (212), 
are able to complement ICP0-negative viruses and give true titers of infectious virus.  We 
compared the ability of n212, RF, R8507, R8508, and KOS to form plaques on L7 cells, U2OS 
cells and Vero cells (Table 2). 
Comparing L7 cell to Vero cell plaqueing ability can give a rough estimate of the defects 
caused by the various mutations in ICP0.  n212, which is completely lacking ICP0 expression, 
showed approximately a 100-fold defect in plaque formation on Vero cells.  KOS and R8508; 
which are wild-type ICP0, and mutated ICP0 showing no deficiency, respectively; plaqued at 
essentially the same efficiency on both Vero and L7 cells.  RF, containing point mutations in the 
RING finger region that abrogate its function, had an approximately 30-fold plaque-forming 
defect on Vero cells, while R8507, which cannot bind CoREST, had a plaque-forming defect on 
Vero cells of slightly less than 3-fold.  These results imply that while most of the function of 
ICP0 is contained in the RING finger region, that CoREST binding is important for part of 
ICP0’s function. 
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Table 2.  Comparison of plaque-forming ability in L7 and Vero cells. 
Virus L7 : Vero Ratio Standard Error 
 
n212 105.0 10.7
RF 28.5 4.1
R8507 2.7 0.4
R8508 1.1 0.1
KOS 1.2 0.1
 
4.4.2 RNA expression from quiescent genomes upon reactivation by ICP0 mutants 
Much of the work concerning mutations in ICP0 has been focused on lytic infection.  In order to 
determine how the RING finger and CoREST binding regions affect gene expression and 
chromatin structure upon reactivation from a highly repressed state, a quiescent cell culture 
model was employed.  Previously, it was seen that MRC-5 cells were among the cell types that 
were most repressive to HSV-1 gene expression in the absence of ICP0 (246).  Quiescence in 
MRC-5 cells was established with the viral mutant d109, which expresses no IE genes and 
contains a GFP reporter gene under control of the HCMV IE promoter (211).  Cells were 
infected with d109, placed at 37°C for 24 hours, then moved to 34°C for 6 days.  d109-infected 
cells were then either mock superinfected or superinfected with HSV-1 mutants lacking ICP0 
(n212), the RING finger mutant (RF), a CoREST binding mutant (R8507), a control mutant with 
mutations in the CoREST binding region which do not affect CoREST binding (R8508), or wild-
type KOS.  Superinfected cells were placed at 37°C, and 4 hpi, before the onset of viral 
replication, RNA was harvested for analysis by RT-PCR (Figure 17A). 
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 Figure 17.  Abundance of GFP mRNA in d109-infected MRC-5 cells (A) or Vero cells (B) after superinfection. 
Infections, RNA isolation, cDNA preparation, and RT-PCR were performed as described in Materials and Methods.  
Quiescent infection by d109 was established for 1 week.  The graphs indicate the number of RNA molecules of GFP 
per μg RNA at 4 h p.i. after superinfection by the indicated virus. 
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One week after d109 infection, expression of GFP RNA reached a steady state level of 
approximately 5x105 copies per µg of total RNA.  Superinfection with n212 caused no increase 
in RNA expression.  This was also the case for RF, indicating that in the absence of a functional 
RING finger, the other domains of ICP0 are unable to activate gene expression from repressed 
viral genomes.  In contrast, superinfection with R8508 or KOS led to a 1000-fold increase of 
GFP RNA.  Superinfection with R8507 caused an intermediate amount of reactivation.  ICP0 
lacking CoREST binding activated expression from quiescent d109 by 2 orders of magnitude, 
but remained 10-fold lower than the reactivation of gene expression induced by wild-type ICP0.  
These results indicated that some of the ability of ICP0 to reactivate gene expression from highly 
repressed genomes was lost when CoREST binding was abrogated, but that the RING finger was 
absolutely required for any ICP0 function.  This led us to test whether RF and R8507 could 
complement one another in trans.  Somewhat surprisingly, the two ICP0 mutants were not able 
to efficiently complement one another in trans, indicating that both functions of ICP0 must 
reside on the same molecule for full reactivation of quiescent genomes. 
Previously, it had been shown that Vero cells were less repressive to HSV-1 gene 
expression than MRC-5 cells (66, 246).  In order to determine whether the RF or R8507 mutants 
were able to overcome a less repressive state, d109 quiescence was established for one week in 
Vero cells, followed by superinfection (Figure 17B).  The steady state level of GFP RNA per µg 
total RNA appeared slightly lower in Vero cells than in MRC-5, but this was due to the lack of 
contact inhibition and overgrowth of cells in the week following infection with d109.  While this 
fact made the quantitative change in gene expression appear less pronounced, the qualitative 
changes in gene expression induced by the various ICP0 mutants mimicked those seen in MRC-5 
cells.  n212 and RF did not increase the level of GFP RNA, while R8508 and KOS derepressed 
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quiescent d109 and allowed an increase in GFP RNA of 2 orders of magnitude.  R8507 was able 
to partially activate GFP expression from repressed d109, increasing RNA levels 5-fold over 
mock infection, but this level of RNA was approximately 14-fold less than that induced by wild-
type ICP0.  The RF and R8507 mutants were again not able to complement each other. 
Since it appeared that both Vero and MRC-5 cells had fully established repression of 
d109 by 7 days post infection, the ability of the various mutants to reactivate d109 GFP 
expression after d109 quiescence was established for one day was tested (Figure 18).  In MRC-5 
cells, the baseline level of GFP expression from d109 was approximately 10-fold greater at one 
day than at 7 days post infection (Figure 18A).  Thus, it takes greater than 24 hours for MRC-5 
cells to fully establish repression on quiescent genomes.  However, the level of activation from 
wild-type ICP0 was similar to that seen when repression was fully established after 1 week.  This 
indicates that even after full epigenetic repression of d109, wild-type ICP0 was able to 
completely remove barriers to gene expression.  RF and R8507 showed similar phenotypes to the 
more highly repressed state, with RF being unable to reactivate gene expression, R8507 
displaying a partial ability to reactivate GFP expression, and the mutants unable to complement 
one another.   
Vero cells have not fully repressed d109 at 24 hpi (66).  The baseline level of GFP 
expression was thus much higher – approximately 2 orders of magnitude – than in cells infected 
for 7 days (Figure 18B).  Thus, it was difficult to discern changes in gene expression induced by 
ICP0, since full expression induced by wild-type ICP0 was only 10-fold greater than in the 
absence of ICP0.  The qualitative findings remained the same, however.  RF failed to activate 
GFP expression from d109, there was a slight increase in expression upon superinfection with 
R8507, and the two mutants failed to complement one another. 
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Figure 18.  Abundance of GFP mRNA in d109-infected MRC-5 cells (A) or Vero cells (B) after superinfection. 
Infections, RNA isolation, cDNA preparation, and RT-PCR were performed as described in Materials and Methods.  
Quiescent infection by d109 was established for 24 hours.  The graphs indicate the number of RNA molecules of 
GFP per μg RNA at 4 h p.i. after superinfection by the indicated virus. 
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 Figure 19.  Abundance of GFP mRNA in d109-infected MRC-5 cells (A) or Vero cells (B) after superinfection. 
Infections, RNA isolation, cDNA preparation, and RT-PCR were performed as described in Materials and Methods.  
The graphs indicate the number of RNA molecules of GFP per μg RNA at 4 h p.i. after coinfection by the indicated 
viruses. 
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Finally, in order to determine the effects on completely unrepressed genomes, the level of 
GFP expression induced by the various forms of ICP0 when coinfected with d109 was 
established (Figure 19).  In MRC-5 cells, coinfection with d109 and HSV-1 expressing wild-type 
ICP0 yielded a 330-fold increase in GFP RNA at 4 hpi as compared to infection with d109 alone 
(Figure 19A).  RF did activate gene expression, and there was at best a small increase in GFP 
expression induced by coinfection with R8507.  In Vero cells, where repression is delayed, there 
was only a 2-to-3-fold increase in GFP expression when d109 was coinfected with HSV-1 
expressing wild-type ICP0, and there was no increase in gene expression in the presence of any 
of the ICP0 mutants (Figure 19B).  These results indicate that both the RING finger and 
CoREST binding regions of ICP0 are involved in derepression of quiescent virus, which is 
increasingly repressed, likely by chromatin structure, over time.  Thus, we explored the ability of 
the various forms of ICP0 to affect the chromatin structure of highly repressed, quiescent d109 in 
MRC-5 cells. 
4.4.3 Changes in chromatin structure of highly repressed quiescent d109 induced by ICP0 
mutants 
Previously it has been shown that ICP0 expression prevents the accumulation of higher-order 
chromatin structure, repressive histone modifications, and histones on viruses entering 
quiescence (66).  In order to determine the effects of ICP0 mutants on the chromatin structure of 
quiescent virus, MRC-5 cells were infected with d109, and one week later, were either mock 
superinfected or superinfected with n212, RF, R8507, R8508, or KOS.  4hpi, ChIP was 
performed. 
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Figure 20.  Repressive chromatin modifications associated with the HCMV promoter of d109 in MRC-5 cells 
after superinfection. 
 
Quiescent infection by d109 was established for 1 week.  Chromatin Immunoprecipitation (ChIP) with antibodies to 
HP1γ (A) and H3K9me3 (B), and followed by RT-PCR were performed as described in the Materials and Methods.  
Graphs show the percentages of total genomes bound after superinfection with the indicated virus at 4 h post 
superinfection with the indicated virus.  Error bars represent standard error of the mean from multiple experiments. 
 
 
We first looked at the ability of the various mutants to remove HP1γ (Figure 20A).  In a 
previous study, after 24 hours in HEL cells, HP1γ was found on approximately 0.7% of the viral 
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genomes (66).  In contrast, by day 7 post-d109 infection, HP1γ was bound to almost 2.5% of 
HCMV promoters.  Superinfection with the ICP0-negative mutant n212, as well as the RF 
mutant, did not cause the removal of HP1γ from quiescent d109 genomes.  KOS and R8508 
superinfection led to an almost complete removal of HP1γ from d109, while R8507 
superinfection resulted in an approximately 25% reduction of HP1γ from the d109 genome.  
These results correlate with GFP expression. 
Modification of histone tails are associated with changes in transcriptional 
permissiveness, and some of these modification allow for the recruitment of proteins involved in 
transcriptional activation or repression (112).  Trimethylation of histone H3 lysine 9 (H3K9me3) 
is associated with repression and serves as a docking site for HP1γ (201, 218).  Using ChIP, the 
relative abilities of ICP0 mutants to cause the removal of this heterochromatin mark were 
assessed (Figure 20B).  Superinfection with n212 or RF was not able to cause the removal of 
H3K9me3, and RF superinfection may in fact have resulted in a slight increase in H3K9me3 on 
the d109 HCMV promoter.  R8507 superinfection resulted in an approximately 40% decrease in 
H3K9me3, while R8508 and KOS superinfection resulted in a complete loss of H3K9me3 from 
the d109 HCMV promoter. 
ICP0 expression prevents histone H3 association with the viral genome during the entry 
into quiescence (66), and during lytic infection (29).  The various ICP0 mutants were tested for 
their ability to remove histones H3 and H4 from the quiescent d109 genome (Figure 21).  As in 
previous experiments, n212 and RF were not able to remove either histone H3 (Figure 21A) or 
H4 (Figure 21B).  Similarly to H3K9me3, RF superinfection may have caused a slight increase 
in histone levels on the d109 HCMV promoter.  Again, while KOS and R8508 superinfection 
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caused an almost complete reduction in histone levels on the d109 HCMV promoter, R8507 
superinfection resulted in a partial reduction in histone H3 (~30%) and histone H4 (~55%). 
 
Figure 21.  Binding of histones H3 and H4 to the HCMV promoter of d109 in MRC-5 cells after 
superinfection. 
 
ChIP with antibodies to histones H3 and H4, and RT-PCR were performed as described in the legend to Figure 20 to 
determine the percentages of genomes bound by histones H3 (A) and H4 (B).  Graphs show the percent of total 
genomes bound at 4 h post superinfection with the indicated virus.  Error bars represent standard error of the mean 
from multiple experiments. 
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Since the R8507 mutant does not disrupt the REST/CoREST/HDAC1/2/LSD1 repressive 
complex, it was of interest to investigate the effects of the mutations in ICP0 on histone 
acetylation levels and histone H3 lysine 4 dimethylation.  In order to account for the drastically 
different levels of histones on d109 after superinfection with each virus, levels of AcH3 (Figure 
22A) and H3K4me2 (Figure 23) were normalized to total histone H3 (Figure 21A), and levels of 
AcH4 (Figure 22B) were normalized to total histone H4 (Figure 21B).  Levels of AcH3 on 
quiescent d109 were extremely low, and superinfection with R8508 or KOS resulted in a 10-fold 
increase in hyperacetylation of histone H3 (Figure 22A).  n212, RF, and R8507 superinfection 
did not result in an increase in hyperacetylation of histone H3.  Essentially the same results were 
seen when hyperacetylation of histone H4 on the quiescent d109 genome was measured, 
although the quantitative changes differed slightly (Figure 22B).  R8508 superinfection resulted 
in an approximately 75-fold increase in hyperactylation of the d109 promoter, while KOS 
superinfection resulted in a 150-fold increase.  RF and n212 superinfection led to no increase in 
H4 hyperacetylation, and there was at most a 4 fold increase of H4 hyperacetylation on the d109 
HCMV promoter after R8507 superinfection. 
Since LSD1 is a component of the CoREST repressor complex, and LSD1 is responsible 
for a removal of H3K4me2, levels of this mark of active transcription were also assayed by ChIP 
(Figure 23).  Quiescent d109 genomes had undetectable levels of H3K4me2 on the HCMV 
promoter, and n212 did not affect the level of H3K4me2.  RF and R8507 superinfection resulted 
in very little increase in the amount of bound histone H3 bearing this mark.  R8508 
superinfection resulted in a 2-to-3-fold increase in the levels of H3K4me2, while KOS 
superinfection increased the levels of histone H3 bearing H3K4me2 by 10-fold.  The results from 
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ChIP are consistent with the RNA expression patterns seen upon superinfection with viruses 
providing mutant ICP0. 
 
Figure 22.  Binding of hyperacetylated histone H3 (AcH3) and hyperacetylated H4 (AcH4) to the HCMV 
promoter of d109 in MRC-5 cells after superinfection. 
 
ChIP with an antibody to AcH3 (A) and AcH4 (B) and RT-PCR were performed as described in Figure 20 to 
determine the percentage of d109 genomes bound by AcH3 or AcH4 at 4 h post superinfection with the indicated 
virus.  In order to compensate for the changing amounts of total histone H3 and H4, AcH3 was normalized to the 
amount of histone H3 (A) and AcH4 was normalized to the amount of histone H4 (B) on the genome by dividing the 
percent of acetylated histone by the percent of total histone (Figure 21).  Error bars represent standard deviations 
from multiple experiments. 
 110 
 Figure 23.  Binding of histone H3 dimethyl lysine 4 (H3K4me2) to the HCMV promoter of d109 in MRC-5 
cells after superinfection. 
 
ChIP with an antibody to H3K4me2 and RT-PCR were performed as described in Figure 20 to determine the 
percentage of d109 genomes bound by H3K4me2 at 4 h post superinfection with the indicated virus.  In order to 
compensate for the changing amounts of total histone H3, H3K4me2 was normalized to the amount of histone H3 on 
the genome by dividing the percent of acetylated histone by the percent of total histone (Figure 21).  Error bars 
represent standard deviations from multiple experiments. 
 
4.5 DISCUSSION 
ICP0 is multifunctional protein, with several seemingly distinct functional domains, each 
contributing to its overall effects.  The E3 ubiquiting ligase function of the ICP0 RING finger in 
exon 2 has been shown to cause the degradation of numerous proteins, the most relevant to this 
study being components of the ND10 bodies, including PML and Sp100 (25).  Additionally, the 
C-terminus of ICP0 is required for its full function, and has been shown to interact with, and 
disrupt, the transcriptionally repressive complex REST/CoREST/HDAC1/2/LSD1 (78, 80, 81, 
83).  Through these, and possibly other, functions, ICP0 is able to prevent the accumulation of 
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heterochromatin on viruses entering quiescence (66).  Since ICP0 is required for the efficient 
reactivation of quiescent HSV-1, it was of interest to determine the ability of various mutants of 
ICP0 to reactivate gene expression and cause changes in chromatin structure of highly repressed 
and chromatinized HSV-1.  Both the ND10 bodies and the CoREST repressive complex are 
implicated in repression of transcription from HSV-1, and it is likely that this repression is 
mediated through an increase in heterochromatin on the quiescent genomes.  We therefore used 
mutant viruses that were either lacking the RING finger activity, or the ability to disrupt the 
CoREST repressive complex, and compared their ability to alter chromatin to reactivate gene 
expression from the HCMV promoter on the GFP reporter gene found in quiescent d109 
genomes.   
Initially, expression of the GFP reporter gene was characterized in MRC-5 cells, one 
week after infection with d109.  In the absence of superinfecting virus, the steady state-GFP 
level was approximately 10 copies per cell.  4 hours after superinfection with KOS or R8508, the 
level of GFP was 104 copies per cell.  The ICP0-negative mutant n212 was not able to activate 
gene expression from quiescent d109, and the RING finger mutated virus RF was also unable to 
reactivate gene expression.  R8507 was able to reactivate GFP expression to a level 10-fold 
lower than wild-type ICP0, but 100-fold higher than the level of GFP produced by quiescent 
d109 (Figure 17). 
Since it has been previously shown that cell type and time-post-infection are important 
factors in epigenetic repression of HSV-1 (66), and since primary human fibroblast cells, such as 
MRC-5 cells, are the most repressive cell type to HSV-1 gene expression in the absence of ICP0 
(246), Vero cells were also tested to determine if a less repressed state was more easily 
reactivated by the various mutants of ICP0 (Figure 18).  Additionally, the ability of the ICP0 
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mutants to activate GFP expression from d109 under lower levels of epigenetic repression was 
tested by measuring induced gene expression 1 day post d109 infection (Figure 19).  The 
quantitative results differed somewhat among the various conditions tested, however, the 
qualitative abilities of RF, R8507 and wild-type ICP0 to reactivate gene expression was 
consistent.  In both Vero and MRC-5 cells, once quiescence was established, a functional RING 
finger was absolutely required to reactivate GFP expression.  The ability to disrupt CoREST was 
not required for an increase in transcription, but was required for full activation of gene 
expression from quiescent viruses.  These data show that in the absence of a functional RING 
finger, disruption of the CoREST repressor complex is not sufficient to reactivate transcription.   
Additionally, in no circumstances was superinfection with both RF and R8507 able to 
activate transcription above the level induced by R8507.  Thus, both functional domains must be 
on the same molecule in order to fully activate transcription.  This may be a result of aberrantly 
localized ICP0, as the RING finger mutant cannot exit the ND10 bodies (83, 182), and R8507 is 
delayed in ICP0 translocation to the cytoplasm (83).  Alternatively, the RING finger and 
CoREST binding region may need to occupy the same physical space simultaneously, and 
location on two separate molecules may prevent this. 
At all levels of repression, wild-type ICP0 activated transcription to a similar extent.  
This indicates that wild-type ICP0 is able to fully remove chromatin structure and activate 
transcription, to levels previously seen for tk and gC during lytic wild-type infection 8h p.i. (66).   
One interesting difference was seen when d109 was coinfected with the ICP0-mutant 
viruses, which results in no time for epigenetic repression to be established before provision of 
ICP0.  In both MRC-5 and Vero cells, neither RF, nor R8507 was able to significantly activate 
GFP expression (Figure 19).  This points to a role for the CoREST binding region of ICP0 in 
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transcription during the lytic phase of the viral life-cycle that may differ from its role in 
reactivation from quiescence.   
It has been established that quiescent virus can be found in a heterochromatic state, and is 
associated with higher-order chromatin proteins, such as HP1α and HP1γ (32, 66).  In order to 
determine the relative ability of the ICP0 mutants to affect this structure in relation to their 
abilities to reactivate transcription, ChIP was performed.  Superinfection with n212 or RF had no 
effect on the association of HP1γ with the d109 genome, while KOS and R8508 superinfeection 
caused an almost complete removal of HP1γ (Figure 20A).  R8507 superinfection resulted in a 
partial removal of HP1γ from d109.  The same pattern was seen for H3K9me3 (Figure 20B), a 
mark of repressive chromatin that serves as a binding site for HP1γ.   
ICP0 expression has been shown to prevent histone H3 association with the HSV-1 
genome, both during lytic infection, and during the entry into quiescence (29, 66).  The abilities 
of the various ICP0 mutants to cause the removal of histone H3 and histone H4 mimicked their 
abilities to remove heterochromatin, with n212 and RF unable to cause histone removal, R8508 
and KOS superinfection resulting in almost complete removal, and R8507 causing an 
intermediate removal of histones (Figure 21). 
The inability of the RING finger mutant to remove chromatin structure from d109 is 
consistent with its lack of transcriptional activation.  The available evidence indicates that 
degradation of cellular proteins mediated by the RING finger is required before the action(s) of 
the ICP0 C-terminus are able to cause an increase in transcriptional activity.   The RING finger is 
responsible for the degradation of the ND10 organizing proteins PML and Sp100.  The ND10 
bodies have been implicated in viral silencing (50), and there is a significant link between 
components of these bodies and epigenetic regulation of transcription.  Members of the HP1 
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family are associated with Sp100, forming a link between ND10 bodies and chromatin.  Both 
HP1 and the splice variant Sp100-HMG have the ability to act as transcriptional repressors when 
bound to a promoter (220).  Additionally, ND10 components ATRX and hDaxx can also be 
found at heterochromatin, interact with one another, and are members of a repressive complex 
that has SWI/SNF chromatin remodeling activity (107, 243, 277).  Depletion of PML, Sp100, 
ATRX, or hDaxx (62, 63, 155) can increase the transcription from ICP0-negative HSV-1 
mutants, directly implicating disruption of ND10 bodies with changes in the chromatin state of 
quiescent viral genomes. 
The intermediate phenotype of R8507 is also consistent with previous findings that show 
a decrease, but not complete elimination, of transcription from viral promoters due to various C-
terminal truncations (21-23).  Further evidence that ND10 bodies play an important role in the 
maintenance of heterochromatin on quiescent genomes is that R8507, which eventually causes 
the degradation of PML, is delayed for this activity (83).  Additionally, the ICP0 mutants D13 
and D14, which contain deletions of the amino acids 633-680 and 680-720, respectively, are 
impaired in ND10 localization (160).  These deletions overlap the portion of ICPO required to 
bind CoREST, which falls between amino acids 668-718 of ICPO.  The amino acid substitutions 
of R8507 are D671A/E673A, further implicating the region between amino acids 633 and 720 in 
partially increased transcription, as well as an intermediate decrease in heterochromatin.   
Since R8507 is deficient in disruption of the CoREST repressor complex, it follows that 
this would lead to a decrease in acetylated histones by the HDAC1/2 portion of this complex, as 
well as a decrease in H3K4me2, a mark of active transcription that is removed by LSD1.  By 
ChIP, it was found that the histone H3 remaining bound to the d109 genome was hypoacetylated, 
and that n212, RF, and R8507 were unable to cause acetylation of histone H3 bound to d109 
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(Figure 22A).  In contrast, there was a greater than 10-fold increase in hyperactylation of d109-
bound histones after KOS superinfection.  The hyperacetylation of histone H4 followed a 
somewhat similar pattern: RF and n212 superinfection failed to induce histone H4 acetylation, in 
this case R8507 superinfection upregulated AcH4 very slightly (approximately 4-fold), while 
KOS superinfection caused a 150-fold increase in acetylation of the histones bound to d109 
(Figure 22B).   
There is a small increase in the dimethylation of d109-bound histone H3K4 after 
superinfection with both RF and R8507, as compared to superinfection with n212, whereas KOS 
superinfection leads to an approximately 10-fold upregulation in H3K4me2 over RF and R8507 
(Figure 23).  R8508 superinfection caused large, but not wild-type level increases in 
hyperactylation of both histone H3 and H4, and a small increase in H3K4me2, suggesting that 
although the mutations in the CoREST binding region do not impair CoREST repressor 
disruption or transcription in cell culture, there may be other, more subtle, effects on its function.   
The inability of R8507, with a functional RING finger, to cause a significant increase in 
hyperacetylation of histones is consistent with an important, but not required role for the 
disruption of the CoREST repressor complex in derepression of quiescent genomes.  It may be 
that once heterochromatin is removed from the genome, that hyperacetylation of histones and 
H3K4 dimethylation are important in maintaining a euchromatic state. 
Our results add to the hypothesis that the ND10 bodies are linked to the chromatin 
compartment through multiple protein interactions, and that ICP0 targets the ND10 bodies as a 
mechanism to remove heterochromatin, both in lytic infection and during the reactivation from 
latency.  Additionally, this study confirms a function for the disruption of the 
REST/CoREST/HDAC1/2/LSD1 repressor complex, and suggests that there may be more 
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functions associated with the C-terminal region of ICP0.  The RF is necessary and sufficient for 
reactivation of quiescent genomes, but for full removal of heterochromatin, increase in 
euchromatin, and activation of transcription , the disruption of the CoREST repressor is required.  
Previously, it was seen that in the absence of ICP0, quiescent genomes were impaired in rescue 
by reactivation or recombination with replicating HSV-1, and that this effect was amplified when 
quiescence was established for three days.  Additionally, as time progressed after d109 infection, 
the ability of the HDAC inhibitor TSA to reactivate GFP expression gradually decreased (246).  
These observations, along with the results of the current study, support a model in which 
quiescent HSV-1 is increasingly heterochromatinized as time progresses, that this higher-order 
chromatin structure prevents access to the genome by transcription factors and proteins involved 
in viral replication, that expression of ICP0 causes the removal of heterochromatin from the viral 
genome through the action of the RING finger, and that ICP0 maintains a euchromatic state on 
the genome by interfering with multiple cellular pathways, thus allowing a generalized increase 
of viral transcription. 
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5.0  SUMMARY AND GENERAL DISCUSSION 
5.1 SUMMARY OF RESULTS  
ICP0 is a promiscuous transactivator of gene expression, which mediates its effects through 
indirect mechanisms.  As such, study of this molecule gives insight into cellular pathways 
targeted by Herpes Simplex Virus Type 1 (HSV-1) to increase its gene expression and counteract 
the host response to incoming viral genomes.  The study presented here models the effects of 
chromatin structure on viral gene expression, both during the entry into quiescence, and during 
reactivation from a repressed state.  Additionally, the effects of cell type and ICP0 expression on 
viral chromatin structure were determined. 
A cell culture model of quiescence modeling aspects of in vivo latency was used to probe 
the effects of cell type and ICP0 expression on the entry of HSV-1 into quiescence (66).  It has 
been shown that, in the absence of ICP0, HEL cells are among the most repressive to viral gene 
expression, while Vero cells are able to repress viral gene expression to an intermediate extent 
(246).  Either HEL or Vero cells were infected with the viral mutants d109 or d106, followed by 
analysis of gene expression and chromatin structure.  The viral mutant d109 lacks all 5 
immediate early (IE) genes.  It expresses a GFP reporter under control of the HCMV promoter.  
d109 is non-toxic to cells and can establish long-term quiescent infection in cell culture.  Gene 
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expression from d109 can be reactivated by provision of ICP0 in trans.   d106 expresses the GFP 
transgene, as well as ICP0, but is deleted for the other 4 IE genes (211). 
Real Time PCR was used to characterize gene expression from the model promoters 
HCMV, an extremely strong promoter; tk, an early (E) gene; and gC, a late (L) gene.  For all 
three genes and in both cell types, d109 expression decreased over time, indicating an increasing 
repression of viral gene expression.  In d106 infection, GFP and tk expression increased over 
time, while gC expression decreased.  In all cases, expression in the presence of ICP0 (d106) was 
greater than in the absence of ICP0 (d109).  Additionally, expression was generally greater in 
Vero cells than in HEL cells. 
Since HSV-1 DNA is not extensively methylated, and viral gene expression is globally 
repressed during latency, it has been hypothesized that gene expression is controlled by 
chromatin structure (128).  We therefore explored the chromatin structure of d109 and d106 in 
Vero and HEL cells by micrococcal nuclease digestion and chromatin immunoprecipitation 
(ChIP). 
Although nucleosomes can be found on latent HSV-1 genomes (110), the presence of 
nucleosomes has not been established during productive HSV-1 infection (95, 96, 117, 136, 
172).  In order to determine the nucleosomal association with viruses entering quiescence, 
micrococcal nuclease digestion was employed.  The pattern of digestion suggested that while 
some of the genomes may have been contained in a nucleosomal structure, most of the genomes 
were irregularly associated with chromatin and, at early times post infection, many viral 
genomes entering quiescence did not have a fully established chromatin structure. 
To determine the association of histones with HSV genomes in a more direct manner, 
ChIP was employed.  It was seen that histone H3 was found on d109 in both cell types and 
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increased over time, and that ICP0 expression from d106 reduced histone association and 
prevented it from increasing.  The amount of gene expression did not correlate to the association 
of histone H3, indicating that histone H3 was not simply being removed as a consequence of 
transcription.  Additionally, the histones that were bound to the d106 genome were 
hyperacetylated, which is a mark of active transcription. 
In order to characterize the increase in heterochromatin over time, which correlated with 
a decrease in transcription, the amounts of repressive chromatin mark histone H3 trimethyl lysine 
9 (H3K9me3), and heterochromatin protein 1γ (HP1γ) were measured by ChIP.  ICP0 expression 
caused a large decrease in the amount of both H3K9me3 and HP1γ in both cell types examined, 
while d109 was increasingly associated with both marks of repressive chromatin in HEL cells.  
In Vero cells, only the gC promoter of d109 acquired significant HP1γ association.  This 
correlated with the gene expression data, and the greater ability of d109 to express the GFP 
transgene in Vero cells than in HEL cells.  
The study of chromatin structure and gene expression upon entry into quiescence 
demonstrated that the level and kinetics of epigenetic repression vary by cell type, and that ICP0 
has numerous functions in addition to increasing the acetylation of histones.  It may act as a 
central epigenetic switch early in infection in determining chromatin structure of the virus.  
Expression of ICP0 prevented HP1γ association with the virus in both cell types on all 
promoters.  It may do this by increasing acetylation of histones, specifically on H3K9, thus 
decreasing H3K9me3 and preventing HP1γ association.  ICP0 expression also prevented histone 
H3 association with the virus.  This is a function not previously ascribed to ICP0 and may reflect 
interference with histone chaperones.  After the removal of chromatin, the level of gene 
expression is dependent on promoter strength.  
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In order to determine the effects of ICP0 expression on previously established 
heterochromatin, d109 was allowed to establish quiescence in MRC-5 cells which, like HEL 
cells, are primary human fibroblasts that are highly repressive to HSV-1 gene expression in the 
absence of ICP0.  One week after d109 infection, ICP0 was expressed in trans by superinfection 
to reactivate gene expression.  ICP0 was provided either by d105, which, like d106, 
overexpresses ICP0, but does not contain the GFP transgene, or by an adenovirus, 
Ad.S11E4(ICP0), expressing ICP0 at levels similar to those during the first several hours of 
wild-type infection. 
By 2 hours after superinfection with d105, the level of GFP expression from d109 was 
increased approximately 10-fold, and by 24 hours post-d105 infection, the level of GFP was 3 
orders of magnitude greater than mock-superinfected cells.  Ad.S11E4(ICP0) superinfection also 
increased the level of GFP RNA by approximately 1000-fold over superinfection with empty 
vector, indicating that even a small amount of ICP0 can fully reactivate gene expression from 
quiescent genomes, and that no other HSV-1 proteins are required for reactivation of gene 
expression.  Additionally, ICP0 expression from Ad.S11E4(ICP0) resulted in large increases of 
gene expression from the model E and L genes tk and gC, indicating that the effect of ICP0 is 
general across the viral genome, and not specifically linked to the HCMV promoter. 
Utilizing ChIP to determine the chromatin structure of quiescent d109 upon d105-
mediated reactivation, it was seen that heterochromatin was removed upon ICP0 expression, and 
that the removal of HP1γ and H3K9me3 was coincident with the induction of gene expression.  
By using Ad.S11E4(ICP0), it was also determined that expression of small amounts of ICP0 
resulted in the removal of heterochromatin from quiescent d109, and that this effect was general 
across the viral genome. 
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Since ICP0 expression resulted in a decrease in histone H3 association with HSV-1 
genomes entering quiescence (66), the effects of ICP0 expression on histone H3 and H4 
association with quiescent d109 were quantified by ChIP.  As with heterochromatin, upon d105 
superinfection, both histones H3 and H4 are removed from the quiescent d109 HCMV promoter.  
Micrococcal nuclease digestion was used to further visualize the effects of ICP0 expression on 
quiescent d109 chromatin structure.  The GFP gene of quiescent d109 genomes was highly 
resistant to micrococcal nuclease digestion, indicating that quiescent genomes were in a 
chromatin structure that was less accessible to the enzyme than general cellular DNA.  This was 
consistent with the ChIP data indicating a highly heterochromatinized state of d109.  
Superinfection with d105 resulted in a chromatin structure of the d109 GFP gene that was 
rapidly degraded by micrococcal nuclease, and may have been even more susceptible to 
degradation than the general cellular DNA.  These results were complementary to the ChIP data, 
demonstrating that ICP0 expression results in removal of chromatin from quiescent HSV-1 
genomes. 
Interestingly, Ad.S11E4(ICP0) expression of small amounts of ICP0 did not result in the 
removal of histone H3 from the d109 genome, and histone H4 was removed only to a small 
extent.  This is consistent with a previous report that characterized the effects of an adenovirus 
expressed ICP0 on histone H3 association (32).  Although Ad.S11E4(ICP0) expression of ICP0 
did not result in histone H3 removal from quiescent d109, GFP expression was equivalent to that 
induced by d105 superinfection.  This indicates that histone removal is not absolutely required 
for reactivation of gene expression. 
Both d105 and Ad.S11E4(ICP0) superinfection resulted in a small increase in the 
acetylation of remaining histones on d109.  However, after d105 superinfection, acetylation of 
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histones followed derepression of gene expression, suggesting that this is either a bystander 
effect of of ICP0 on chromatin structure, or that acetylation of histones is a means by which the 
virus maintains a euchromatic state during reactivation. 
In order to further investigate the effects of ICP0 on quiescent HSV-1 chromatin 
structure, and to delve further into the mechanism by which these effects are mediated, a series 
of superinfections with HSV-1 carrying mutations in ICP0 was carried out, and changes in gene 
expression and chromatin structure were characterized with RT-PCR and ChIP.  ICP0 is a RING 
finger E3 ubiquitin ligase, with the RING finger domain found in exon 2 (7, 48, 52, 61).  A 
number of proteins are degraded in a RING finger- and proteasome-dependent manner upon 
expression of ICP0, among which are major constituents of ND10 bodies PML and Sp100 (79) 
and centromeric structural proteins (55, 151, 152).  ICP0 also interacts with and inhibits the 
activity of some class II histone deacetylases in a RING finger-independent manner (153).  The 
C-terminus of ICP0 has also been shown to disrupt the repressive complex 
REST/CoREST/HDAC1/2/LSD1 (78, 80, 81, 83), leading to relocalization of some constituents 
of the complex. 
The viral mutants n212 (does not express ICP0) (23), RF (RING finger function is 
disrupted) (146), R8507 (disruption of CoREST repressor complex abrogated) (83), R8508 
(silent mutations in the CoREST binding region) (83) and the wild-type virus KOS were used to 
superinfect MRC-5 cells harboring quiescent d109, and test the effects of mutations in ICP0 on 
its ability to reactivate GFP expression and alter quiescent viral chromatin structure.  Neither 
n212, nor RF were able to reactivate GFP gene expression from quiescent d109, while both 
R8508 and KOS reactivated gene expression by approximately 1000-fold.  R8507 reactivated 
GFP expression an intermediate amount, 100-fold.  RF and R8507 coinfection were unable to 
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complement each other.  This pattern of reactivation ability was seen in multiple levels of 
epigenetic repression induced by different lengths of establishment of d109 quiescence in 
different cell types. 
The ability of these ICP0 mutants to alter the chromatin structure of quiescent d109 was 
also characterized.  Neither n212, nor RF superinfection was able to cause removal of 
heterochromatin from the d109 HCMV promoter, as measured by HP1γ and H3K9me3 
association.  RF and n212 superinfection also did not result in the removal of histone H3 or H4.  
Both R8508 and KOS were able to cause the removal of heterochromatin and histones, while 
R8507 superinfection caused a partial removal of HP1γ, H3K9me3, histone H3, and histone H4.  
These results are consistent with the gene expression data. 
Since R8507 is responsible for the disruption of the CoREST repressor complex, we also 
measured the ability of the various HSV-1 mutants to cause the hyperacetylation of histones and 
an increase in H3K4me2, a mark of active transcription that can be removed by LSD1 (224).  As 
expected, neither n212 nor RF superinfection resulted in hyperacetylation of histones, while both 
R8508 and KOS superinfections increased the acetylation of both histone H3 and H4.  
Interestingly, R8507 superinfection did not result in hyperacetylation of histone H3, and only 
slight hyperacetylation of histone H4.  Additionally, superinfection with RF or R8507 yielded 
only slight increases of H3K4me2 on d109, while KOS superinfection resulted in a large 
increase in H3K4me2.  This is consistent with an active CoREST repressor complex functioning 
during R8507 infection, and a need for the RING finger and C-terminus of ICP0 to work in 
tandem for full ICP0 activity.   
The results of these studies point to multiple roles for ICP0 in increasing gene expression.  
ICP0 expression results in a decrease in chromatin association on incoming genomes entering 
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quiescence, as well as a removal of previously established chromatin structure on quiescent 
genomes.  Additionally, expression of ICP0 results in the increase of marks of active 
transcription on the viral genome.  These functions appear to intersect in removal of repression 
introduced by the cellular response to incoming viral DNA. 
5.2 ICP0 ACTS AT THE INTERSECTION OF INTERFERON, CHROMATIN, 
CELL-CYCLE, AND DNA DAMAGE RESPONSE PATHWAYS 
ICP0 is required for efficient reactivation from latency (86).  Additionally, in a transgenic mouse 
model, stressors that are known to cause HSV-1 reactivation, such as UV irradiation and 
hyperthermic stress, were shown to upregulate transcription from the ICP0 promoter (148).  It 
has been hypothesized that VP-16, which activates IE gene expression, coordinates the exit from 
latency (248).  Even if ICP0 expression is not the trigger for reactivation, it would still be the 
case that the activity of ICP0 is essential for removal of viral chromatin structure, allowing 
access to viral promoters, efficient reactivation of viral gene expression, and the production of 
progeny virus.  The study of ICP0 gives insight into multiple pathways that cells use to control 
gene expression, including the interferon response, chromatin control of gene expression, cellular 
antiviral mechanisms, and DNA break response pathways. 
In this study, we have used a cell culture model of quiescence to demonstrate the 
importance of cell type and ICP0 expression in the epigenetic control of gene transcription 
during HSV-1 latency.  During the entry into quiescence, ICP0 may act as an epigenetic switch, 
allowing lytic replication to proceed in cells in which ICP0 is expressed, and allowing viral 
genomes to be heterochromatinized in cells in which ICP0 expression is repressed.  Upon 
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reactivation from quiescence, expression of ICP0 is able to cause the removal of 
heterochromatin.  While this function is largely dependent on the ability of the RING finger 
domain of ICP0 to mediate the degradation of a number of proteins, the C-terminal region, and 
the disruption of the CoREST/REST/HDAC1/2/LSD1 repressor complex are required for its full 
activity. 
These studies imply that ICP0 expression disrupts repression of viral transcription.  This 
activity occurs through multiple functional domains of ICP0.  The RING finger domain is an E3 
ubiquitin ligase which causes the degradation of a number of proteins, including two that are 
critical for organizing the ND10 bodies: Sp100 and PML (248).  ND10 bodies are thought to be 
part of the innate cellular response to viral DNA (50), and incoming HSV-1 DNA localizes 
adjacent to ND10 bodies (59, 64, 105, 161).  Several proteins responsible for formation of 
repressive chromatin are found in ND10 bodies, including HP1γ, ATRX, and hDaxx.  HP1γ 
binds to the repressive chromatin mark H3K9me3, has been shown to repress transcription and 
helps to form higher-order chromatin structure (149).  ATRX and hDaxx are members of a 
repressive complex that has SWI/SNF chromatin remodeling activity and can be found 
associated with  heterochromatin (107, 243, 277).  Thus, the removal of heterochromatin 
structure shown in ChIP assays and micrococcal nuclease digestion is most likely due to the 
degradation of a number of proteins by the RING finger of ICP0. 
ICP0 expression has also been shown to cause the acetylation of histones associated with 
viral genomes (29, 32, 66).  This may be an effect due to disruption of repressive complexes 
containing HDACs, rather than actively increasing acetylation.  By disrupting HDAC-containing 
complexes, ICP0 is preventing repression by abrogating the removal of acetylation from 
histones.  ICP0 interacts with, and causes the redistribution of, class II HDACs (153).  ICP0 also 
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interacts with, and causes the disruption of the HDAC-containing repressor complex 
REST/CoREST/HDAC1/2/LSD1 (78, 80, 81, 83).  When point mutations in the CoREST 
binding region (R8507) render ICP0 unable to disrupt this complex, hyperacetylation of histones 
on quiescent genomes was not observed.  Thus, the changes in chromatin induced by ICP0 
expression are likely the result of multiple interactions through several functional domains of 
ICP0, as well as the degradation of multiple proteins. 
While it appears that ICP0 is primarily involved in preventing or removing epigenetic 
repression of viral gene expression, it may also have an active role in increasing gene expression.  
In some cell types, ICP0 has been shown to degrade the catalytic subunit of DNAPK, DNAPKcs 
(133, 188).  DNAPKcs is a repressor of the activity of GCN5, which is a histone 
acetyltransferase (6).  Thus, degradation of DNAPKcs may be a means by which ICP0 further 
increases gene expression through epigenetic mechanisms.  This possibility, and the mechanisms 
by which ICP0 exerts its effects, require additional study. 
The effect of ICP0 on chromatin structure is intimately linked with its other functions.  
Viruses lacking ICP0 are hypersensitive to interferon (91, 169), and the mutants RF and R8507 
have also been shown to exhibit this phenotype (83).  ICP0 blocks the action of interferon 
through multiple mechanisms, including preventing the upregulation of interferon stimulated 
genes through IRF3 and IRF7 signaling (144, 165, 166).  Interferon has been shown to 
upregulate the components of ND10 bodies (54, 244, 245), which ICP0 also targets for 
degradation and dispersal, and are crucial to the shutdown of viral gene expression (62, 63, 65, 
160, 161).  Additionally, the CoREST repressor complex targeted by the C-terminus of ICP0 
localizes adjacent to ND10 (80), as do incoming viral genomes. 
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ICP0 also causes the degradation of the centromeric proteins CENP-A (152), CENP-B 
(151), and CENP-C (55).  This may be an important aspect of ICP0 function, or it may be a 
tangential effect caused by the destruction of ND10 bodies.  HP1, which is removed from viral 
genomes upon ICP0 expression, as well as ATRX and hDaxx, which are constituents of ND10, 
localize both to ND10 bodies and the centromeres (56), linking destruction of centromeric 
proteins by ICP0 with the destruction of ND10 bodies. 
ICP0 also has been shown to inhibit the circularization of viral genomes (108), and 
interferes with the DNA break repair pathway by degrading the H2A ubiquitinating ligases 
RNF8 and RNF 168 and interfering with the localization of DNA repair proteins (143).  
Additionally, DNA repair proteins are recruited to viral replication compartments (50).  The 
cellular protein p53 senses multiple types of DNA damage (145), is at the hub of the DNA 
damage response and acts as a checkpoint protein that can cause cell cycle arrest .  ICP0 interacts 
with, and ubiquitinates, p53, although it does not cause large scale degradation of p53 (15).  
ICP0 expression results in cell cycle arrest at both the G1/S and G2/M checkpoints, and 
upregulation of the p53 responsive genes p21, mdm2, and gadd45 in both a p53-dependent and 
p53-independent manner (97).  ICP0 also interacts with and stabilizes cyclin D3 (116), and 
causes it to localize in the vicinity of ND10 bodies (257), further contributing to the effects of 
ICP0 on the cell cycle. 
These findings, together with the results of the current study, demonstrate the complexity 
of cellular pathways leading to the chromatinization of incoming viral genomes.  As a 
multifunctional protein with numerous interaction domains, as well as enzymatic function, ICP0 
is able to perturb cellular metabolism in a number of ways that results in the removal of 
chromatin from the viral genome.  Further study of the mechanisms of ICP0 action, as well as 
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the cellular response to incoming viral genomes, will yield greater understanding of the 
intersection of transcriptional regulation with numerous cellular pathways. 
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